November 21, 2026 · Global health

First Candidates’ Forum for the election of the WHO Director-General: verbatim transcript (19 November 2026)

Abstract collage of tall standing figures in red, blue, teal and ochre on a cream panel

The Geneva Learning Foundation (TGLF) publishes this transcript so that health workers, ministries of health and other stakeholders can read what was said at the first candidates’ forum for the election of the next Director-General of the World Health Organization (WHO). It covers the second day of the forum, 19 November 2026, when Member States interviewed the remaining three of the seven candidates: Mr Budi Gunadi Sadikin, Dr María Neira and Dr Hanan Balkhy. We could not find an official transcript online, so we prepared this clean verbatim version from the English audio channel of the public webcast. Three days before the forum’s second day, TGLF sent the candidates From guidance to results, an agenda paper available in the six official languages of the United Nations. It sets out six proposals for WHO to operate as a two-way learning system, in which guidance reaches the people who deliver health services and what they learn in applying it returns to their peers, their ministry and WHO. Our feature article explains what ten years of work with community-based health workers suggests the new Director-General should do. It also notes that every candidate has promised results that people can see in countries. Read alongside these two documents, the transcript shows how each candidate answered Member States’ questions about turning that promise into practice.

Morning session

CHAIR: Good morning, everyone. The meeting is called to order. Before proceeding with the interview, may I please verify that all delegations have received the envelope with two tokens for this morning session. I think everyone has received. So we can now proceed with the interview of Mr Budi Gudani Sadikin.

I shall ask the Secretary to bring the candidate to the podium. Good morning, Mr Budi Gunadi Sadikin. Welcome to the First Candidates Forum for the election of Director-General. I wish to thank you for coming to this interview today. I understand that the Secretary has already informed you of the way we shall proceed this morning and I propose that we start immediately with your oral presentation.

Should you, if you have a PowerPoint, you have the floor. The 10 minute period will begin simultaneously with the activation of lighting system.

Interview of Mr Budi Gunadi Sadikin

MR BUDI GUNADI SADIKIN: Excellency, ladies and gentlemen, bonjour. Good morning. The famous poet Robert Frost once wrote, two roads diverged in the wood, and I took the one less traveled by, and that has made all the differences. My path to public health has been that road less traveled. I started with science on the subject known as the mother of all science, physics.

And then I spent 30 years in information technology and finance. And in 2020, at the height of the COVID-19 pandemic, the president tasked me to lead the Indonesian Ministry of Health, to find, to finance, to distribute and deliver more than 400 million jabs to 200 million Indonesian people who live in 7,000 inhabited islands. By mid-2022, he gave me the second task to reform Indonesian healthcare system. Now, these decades across private and public sectors taught me how to convene diverse institutions, mobilize a very large resources, and deliver results at scale. Yet working in health has been especially fulfilling for me because our work saved lives.

And through WHO, we can make a difference in the lives of more than 8 billion people. Today, global health faces unprecedented challenges, significant demographic changes, climate change, new pathogen, new technologies, including funding cuts, and threats to multilateralism. These are unconventional times. Unconventional times require unconventional measures, and it needs unconventional leaders. Who can bring fresh perspective, new ways of working, importantly have track record and courage to reform, and position WHO not suitable only for the past, but well suited for the future.

I know change can bring uncertainty, especially for my WHO colleagues who have been through so much. And let me reassure you that I am running to strengthen WHO as the world’s most trusted health authority and support its dedicated people. That is the purpose of reform and the road less traveled I hope to walk alongside you. Excellency, in recent months I have been in listening mode, meeting around 140 bilaterals with all the Member States. Your voices have shaped my visions.

Healthy long lives for all, a world where everyone, everywhere, can live healthier for longer and access affordable care when they need it. You have also shaped my mission, built on three pillars. First, back to core mandates. Many of you have called WHO to refocus on its core mandates, setting norms and standards grounded in science. As a DG with active participation of countries, I will review and prioritize more than 3,000 resolutions that are mandated to us.

Most of them need dedicated resources, money, and headcounts. And as a DG, I will fully support WHO’s scientific expertise, drawing on experts within and beyond WHO. I have just came from Lyon to see Indonesia flag as the 30th member of IARC, such a great WHO cancer research institutions. As the DGI will lead WHO to navigate on rapid advances in emerging technology, artificial intelligence, robotics, genomic science, and precision medicine, to responsible data governance and parallel safety standards based on principles of equity and affordability. Second, global convening around country priorities.

Health sovereignty must be at the heart of global health corporations and global health architectures. Yet sovereignty doesn’t mean isolation. It means solidarity and equality. Through its convening power, WHO can help countries develop one credible national health plan, one country, one plan, one budget, and to support country to mobilize domestic and external financing and bring partners together behind that plan. We can help countries to digitalize and standardize global and national health data to improve transparency, productivity, and help countries to have better access of quality care at affordable cost of healthcare services to their people.

And to help countries to do market shaping and pooled procurement for essential vaccine, medicine, equipment, following the successful model of our colleagues at PAHO. I’ve seen what strong convening power can achieve. In Indonesia, I helped mobilize more than $8.7 billion US dollars in the last five years in grants and development bank financing, and aligning partners behind national health priorities. At the global level, during Indonesia presidency, G20, I worked with our finance ministers to bring health and finance leaders together, and secured agreement to establish the pandemic fund. And Indonesia sits as a board member in Global Fund, in Gavi, in SEPI, in FIND, in Stop TB Partnerships, because we believe we can do more and better together than alone, and we sit not only as a recipient, but also as donors.

I will bring that political and bridge building skill to WHO, aligning stakeholders behind country priorities and turning vision into collective actions. Lastly, the third pillar, strengthen WHO from within. I have led large institutions across private and public sectors, leading the largest bank in the country with more than 100,000 personnel and 65 billion in US dollars in assets, leading the ministry with more than 70,000 personnel and $7 billion annual budget. That experience taught me that a key of high-performing institution is a leader that is able to set a clear vision, a leader that is able to choose the right people, to give clear targets and authority, and support and hold them accountable for results. On recruitment, I will appoint people on merit for their competence and integrity.

Women hold half of Indonesia Health Ministry leadership positions, so I will advance equal opportunity for women in WHO at all levels. On accountability, I will set better transparency in financial reporting, clear performance indicators, routinely review progress, and hold people accountable for results. And misconduct must be addressed fairly and promptly. On financial sustainability, I will continue Dr Tedros’ great initiative to achieve 50% of WHO budget from assessed contribution by 2031. And I will broaden WHO funding base, align budgets with priorities and make resources used transparent.

Together with regional directors, I will define clear roles and responsibility across all levels, working as one WHO, one mission, one team to serve the countries. Excellency, let me close with something personal. My mother suffered a stroke, the hospital lack of CT scan to diagnose her. She survived but lived with this ability for 15 years before she died. I wonder how different her life might have been with the right care at the right time.

Years later as Health Minister, I had an opportunity and power to act. We must keep our people healthy, not waiting to cure them when they are sick. We did revitalize 10,000 primary healthcare clinics with modern equipment, the NPOCT, X-rays, ultrasound. We launched annual free health screening to more than 100 million of Indonesians and modernized 514 city hospitals with CT scan, cath lab, PET scan, Lienac and all the modern equipment. I cannot change what happened to my mother, but I can work to give other families a different future.

That drives my purpose to serve 280 million Indonesians and it fuels my determination to serve more than 8 billion people to WHO. So, Excellencies, every family wants their loved one to live long and healthy lives. And the power to shape the next chapter of WHO rests in our hands. We can stay on the familiar, old and worn road and hope for different outcomes, or together we can take the road less travel and make all the difference. I will be honored to walk this road alongside you for a WHO that’s strong in science, responsive to countries, and able to execute timely and efficiently.

So everyone, everywhere, our children, the children of our children has the chance to live longer and healthier life. Thank you.

CHAIR: Thank you. We will now continue with the questions and answers. I shall now invite Member States and SAID members wishing to ask the candidate a question to place the yellow token in the receptacles corresponding to their region. May I please ask the Secretary to collect the tokens and display the relevant token on screen. I shall now pull one token from each of the receptacles following the order of the regions previously determined, starting therefore from the Western Pacific region.

Once six tokens, one per region, have been pulled out, I will invite the corresponding Member States or for our associate members

SECRETARY: Nepal Chad Lebanon Canada. Italy.

CHAIR: Those Member States who are getting again and again, I think they should try some lottery. I have noticed also when I pick now, I hesitate. Anyway, the six members that will be given the floor to ask questions in the fifth round are Malaysia, Nepal, Chad, Lebanon, Canada and Italy. We start with Italy.

SECRETARY: No, we start with Malaysia. Okay.

CHAIR: I shall now give the floor to Malaysia to ask questions. The 50-minute period will begin simultaneously with the activation of the lighting system.

MALAYSIA: Thank you, thank you Chair for finally picking Malaysia. Thank you Pak Budi. My question is about middle-income countries. Middle-income countries like Malaysia, we often fall into a missing middle, where we are neither eligible for donor-funded pooled procurement mechanisms, nor do we possess the purchasing power of higher-income countries. Our question is this: During a crisis, we can see that donations do not guarantee equitable access.

We have learned that, among others, it requires strengthened manufacturing capacities in regions like Southeast Asia. Beyond voluntary licensing, if elected, how will you deploy WHO’s normative and technical power to help middle-income countries build regional hubs for vaccines and medicines which us sustainable and commercially viable. I thank you.

CHAIR: Mr Sadikin, you have the floor.

MR BUDI GUNADI SADIKIN: First, I have to apologize to my neighbor in Malaysia because of the case that we export to Malaysia. My apology. I wish Indonesia can do better. So access to medicine at the right price is the issues not only happens in Malaysia, but also in many other countries. And I have learned during my discussions, bilateral meetings with many health ministers, especially from the PAHO region, they have already proven the revolving fund concept that has been there for many, many years.

And I’m so surprised to see that the price of vaccine that Indonesia buy is actually more expensive than they are. So as a board member of Gavi that I noticed also that Gavi do pooled procurement and my deputy said at the board of global fund that also have the WAMBO pooled procurement system, I strongly believe and I become a DG, this is something that I will replicate across the region. And we don’t have to reinvent the wheel. We can talk to our PAHO friends, you know, bring the smartest and the brightest that have experience from PAHO to set up the same things in the other WHO region. That is the convening power that WHO can use.

And this should be easier Because this is the example of convening power among ourselves. We can extend this convening power to Global Fund, to Gavi, to UNICEF, that is aligned with the UNAT reform. And I strongly believe that will give the benefit not only for vaccine, but also for expensive medicine like the cancer treatment. So I wish the Malaysians, the Indonesians, and all 192 countries, Member States of WHO, can have an easy access and quality of medicine at the affordable price. Thank you.

CHAIR: I shall give the floor to Nepal to ask a question.

NEPAL: Thank you, Chair. Thank you, Minister. Thank you for sharing your vision. Unlike most of the candidates, you come to health from an outside sector. You have spent many years in banking and WHO now faces deep budget cuts and growing pressure to show value for money.

And given the financing cuts, our question is about the need to strengthen WHO’s capacity at all three levels. So if elected Director-General, what concrete measures would you take to strengthen the technical, institutional and operational capacity of the organization and also its financial health of the organization at all three levels of the WHO?

MR BUDI GUNADI SADIKIN: The Minister of Health of Nepal is my colleague, Ibu Nisha, sit at the board member of Gavi. And I would like to propose her to be my replacement because we are coming from the same region. To answer your questions, to be honest, I have seen several institutions within WHO with a very strong technical capabilities and fortunately is a very strong funding support. So I just met this, I visited this organization called IR last May. I’m very surprised with the capability to do cancer research.

It’s unparalleled team of researchers that they have and results I’m also very surprised to know that can I be a member? No, no, you cannot. You are a WHO organization. Yes, but we have a different model. So I have to apply and pay the membership fee.

Pay a membership fee. There are 30 members of IYAR. They live on their own budget. The annual contributions of the members is around 20 million US. They top up the other 20 million US for competitive grant and exist as the most trusted with their CI5 report of a WHO research institution that’s setting norm and standard.

So I strongly believe, and in the country, including Indonesia, we pay. We are ready to pay, and this September, in six months, we become the 30th member. So the issue about institution, WHO has it. We just have to replicate this excellence across the whole organization. But I will start from within first.

This is the confining power from within. We can find great institution there. About the money, it is a matter of trust. Those 30 members never complain that they pay for the dues. Why?

Because they can see the benefit. So it is my job as a DG to make sure that we build the trust to all of you. And trust cannot be taken, it has to be earned. I need to earn your trust. When I got your trust, the secretariat earned your trust.

The members will be very happy to pay their excess contributions and hopefully to reach 50% of WHO budget like IARC before 2031. Thank you.

CHAIR: I shall give the floor now to Chad to ask a question.

CHAD: [In French] Merci beaucoup, Monsieur le Président. Bonjour, chers collègues. J’ai une question sur la question de l’accès équitable et durable aux vaccins. [Editor’s translation: Thank you very much, Mr Chair. Good morning, dear colleagues.

I have a question on equitable and sustainable access to vaccines.] Here in Geneva, and during COVID-19, all those who were in post here in their time are witnesses. During a part of the world, the time is to be paused.

CHAIR: Excuse me, can you pause for a while? The translation, there’s some problem with the translation. We’ll restart. Pause the timer also. Thank you.

Do you need to reset the timer? Translation is working. Once it is ready, we will restart. I would request the member from chat to repeat the question. Is it okay now?

Is the translator…

INTERPRETER: Yes, interpretation is working now. Just test interpretation in French. Bonjour Mesdames et Messieurs. Good morning, dear colleagues. I am very pleased to see you here today.

Today, so we can continue.

CHAIR: Okay. Thank you, [name unclear]. It’s working. In French, we can listen in English. So we can restart the question now.

CHAD: Merci. Thank you very much, Mr Chair. I wanted to ask the candidate about equitable and lasting access to vaccines. I mentioned COVID-19 and I was saying that for all those who were working here, we noticed that there was inequitable access. While some people around the world had access to the third dose, some were still waiting for the first.

And this raises the issue of nationalism of vaccines. What we’re not there’s no guarantee that there will not be another pandemic what do you plan to do to ensure that we are protected from such an injustice if in the future there is another pandemic? I thank you.

MR BUDI GUNADI SADIKIN: To emergency medical countermeasures during pandemic it’s something that all of us need to address, especially for my brother and sisters in Africa. I was asked by President Mahama to sit as the co-chair of the Accra Reset, and this is one of the key principles in health sovereignty. So what Indonesia has done, we work with Senegal on the full technology transfer of vaccine manufacturing of our local vaccine manufacturing company. Indonesia has biopharma that exported polio vaccine globally under WHOPQ. And it is our intention to transfer full technology, not only fill and finish, but also the development of the bulk and to do research and development to produce the seed vaccine.

We started with Senegal. Now I’m talking with Ghana and Nigeria. We are also already started with Pakistan. The reason why? Because I believe during pandemic, these emergency medical countermeasures should become public goods.

And we cannot hold the vaccine manufacturing capacity in only certain countries. And we have to have it in the global south. That’s why Indonesia is next year, I will invite you all, if you like, to come to Bali, to the local vaccine manufacturing meeting there. So we can discuss, and not only discuss, but to implement. I believe country with 100 million people and above financially is justified to have their own vaccine manufacturing companies.

Indonesia is ready to do full technology transfer from the beginning until the end help our African colleagues to develop this. Of course, in Africa also need to establish another ecosystem, not the local manufacturing facility. But you also have to develop the regulatory agency with a certain maturity level. And I know in Africa the initiative is already there. I met with my sister Mimi, if I’m not mistaken, that leading the African Medical Regulatory Agency, you have to increase it as quickly as possible to reach maturity level four.

And if I become a DG, I will support Africa Medical Regulatory Agency to reach that level as quickly as possible. Thank you.

CHAIR: I shall now give the floor to Lebanon to ask a question.

LEBANON: Thank you, Mr Chair, for giving me the floor, and thank you, Mr Sadikin, for your presentation and answers. Lebanon’s question is in light of the increasing frequency and complexity of health emergencies, particularly in conflict-affected countries. So if elected, how do you envisage strengthening WHO’s capacity to ensure timely and effective emergency responses, protect healthcare facilities and personnel, and support the continuity and recovery of essential health services, particularly in countries facing multiple and protracted crises? I thank you.

MR BUDI GUNADI SADIKIN: Personally, I feel very sad to see the situations globally. Because I wish the crisis that we have is not human made. In Indonesia this year, I had major flood in three provinces like in Nepal that displaced more than 1 million people. For months after that, I had a 7.7 Richter scale earthquake in eastern Tenggara. Two months after that, I got the largest volcano’s eruption, the Krakatoa in West Java.

And then the forest fire. I think those natural-made crises are enough for me, rather than human-made crises. So I really feel sorry to see this happen. And that is a WHO responsibility to make sure that every one of our members, when crisis happens, we need to make sure that they have access to medical services. But I also have to be honest that maybe the objective is to deliver the healthcare services the easiest, the fastest, the best quality, and the affordability that the world can carry.

And this is the power of WHO to do the convening power with humility. As a Director-General, I will start on my first day to convene with another UN body, or maybe non-government body, to sit together and determine a division of function and roles. Who are actually the best institution that can deliver these services to countries in crisis? We shouldn’t talk about who holds the budget, who gets the spotlight. That is extremely unimportant.

What important is how fast, how efficient we can deliver the service to the country. And by doing that, we can determine in one side maybe that’s the best way for WHO to do it. On the other side, maybe that is the best way for UNICEF to do it. On the other side, maybe that is the best way for a local institutions or NGOs to do it. But we have to prepare at the beginning.

And that is the job of the DG of WHO, by utilizing that enormous convening power to help the country. That should be the focus. Thank you.

CHAIR: I shall give the floor to Canada to ask a question.

CANADA: Thank you, Chair, and thank you, Mr Sadikin, for your presentation. With your election platform position around financial and structural reform, what will you do to enhance WHO’s scientific excellence and authority? Thank you.

MR BUDI GUNADI SADIKIN: Usually, during my career, more than 40 years, I’m always not the smartest people in the room. Because I always dealing with many people smarter than I am. And I feel very lucky to be surrounded by people like them. Because I don’t have to think too much, you know, as those smart people. That happens in COVID.

No medical background coming there, don’t know anything about virus, you know, what is this about COVID, interleukin, whatever. That is a cytokine storm, I don’t understand anything. But I have a lot of scientists which is extremely smart that work for me. So my role as a leader is to prioritize the problem and ask their advice and give them the best support that I can, protecting them for political interventions, providing them with funding. And by the way, I will be very good in it I have the track record and let them guide the path to move forward.

I have no intention to be the smartest people in the room. I am not the smartest people in the room. And WHO has a lot of smart people in the room. And also the Member State has a lot of smart people in the room. My only job is to support them.

Thank you.

CHAIR: [In Italian] Ora daremo la parola all’Italia per [fare] una domanda. [Editor’s translation: Now we will give the floor to Italy for a question.]

ITALY: Minister Budi, [In Italian, as recognized] Indonesia rappresenta che il suo programma del prezegno [screening] gratuito è riuscito a 10 milioni di persone. [Editor’s translation, uncertain: Indonesia reports that its free screening programme has reached 10 million people.] At the same time, in most national budget, prevention is still counted as a cost rather than a measurable investment. Drawing on our experience across finance and health, including the work Italy and Indonesia have done together, what concrete tool would you give countries as Director-General, if elected, to show their finance ministries which prevention investment deliver the best returns?

MR BUDI GUNADI SADIKIN: As a banker, when I joined this job, I love to see numbers. I will quote you some numbers. In the United States, the average life expectancy is 79. And average U.S. Citizens spend 11,900 every year.

In Cuba and Panama, the average life expectancy is also 79. And they spend 1,900, 10,000 U.S. Difference. To reach the same level. Sometimes I joke, when I reach 70, I will migrate to Panama and Cuba.

But of course, people say, Woody, you cannot compare like that. Okay, let’s do it with Japan. My friend Toshi is sitting there. Japan has 84 average life expectancy and it’s spent 5,500. Singapore has 84 life expectancy that’s spent 3,300.

You’re talking about thousands of US dollars. The reason why the Japanese and the Singaporeans live longer and healthier and cheaper, it’s because they focus on to keep people healthy, not to cure when they are sick. And in Indonesia, 140, Malaysia is 400, 300 US different, they are 76, we are 72. If we reach Malaysian level in the next five years, it will be 300 US additional multiplied by 280 million, will be 84 billion US additional cost. If I go to Singapore level in the next 15 years, 3,000 US different multiplied by 280 million, 840 billion additional costs.

That scared my Ministry of Finance. So I told my Ministry of Finance, you better support me to do a better prevention promotion. And it’s simple. I just test four things. I test many 13 or 14 things and now reach 110 million people already.

My target is by 2029, 280 million every year will be tested. But I would like to see hypertension, blood sugar, cholesterol, and I’m sorry, obesity. Because why this four is important? Because the death in Indonesia, number one, is not tuberculosis, HIV, or malaria. It’s stroke, 350,000 per year.

Heart attack, 300,000 per year. You know, cancer, 264,000 per year. And then also kidney problem, 180,000 per year. So I can control the cardiovascular indicators, teach them how to live healthier, like the Japanese or the Singaporean, then I wish I can extend the healthy average life of Indonesia in a much cheaper way. And then when the finance ministers understand there is a scary 840 billion burden in the next 15 years, they say, okay, Budi, I will give you the budget.

But make sure the budget to do more screening and then you give cheap amlodipine to reduce the blood pressure or cheap metformin to reduce the blood sugar. So those people doesn’t have to go to hospital and receive expensive treatment. Thank you.

CHAIR: The first six questions are read out and answers given. The lighting system tracking 50 minute period will now be paused. I shall now ask the Secretary to merge the contents of six receptacles into one and will continue with the selection of Member States or associate members until the time available is exhausted. It. Each time a question is posed and an answer is provided, the lighting system will be activated to track the one minute period for the question and the three minute period for the response respectively.

For the information of the candidate and the members here, we will add 20 minutes due to the disruption of translation at the end. Thank you. I shall now give the floor to Haiti to ask the question. The lighting system tracking the 50-minute period for the question and answer session will be reactivated at the same time.

HAITI: Thank you, Mr Chair. Thank you, Mr Sadikin, for your presentation. My question is as follows. The Americas region has disparities in terms of funding and access to vital services. Small island states and states that face prolonged crises.

What place will you give to Haiti and the Caribbean in your program of working? How do you plan to strengthen complementarity between WHO, PAHO and national institutions to respond to these particular needs? Thank you.

MR BUDI GUNADI SADIKIN: When Indonesia moved to WPRO, I realized that I’ve seen many brothers and sisters. Because Indonesia consists of 17,000 islands and 7,000 of them are inhabited. So in Western Pacific region, I met a lot of countries with similar circumstances. You know, Tonga, Vanuatu, you know, all the country with a small island country. And we’re also facing the same issue on the climate health.

We are facing the same issue how we can deliver access, especially access to the quality healthcare at, you know, the affordable price. So as a DG of WHO, when I see this, we need to create a specific focus, maybe a task force, that setting norm and standard, how we would like to deliver health services for this type of ecosystem. I can envision that we need to have a very strong primary care to avoid as much as possible for those people to be sick and need hospital treatment. Second, we need also to establish a very strong referral system. Referral within the country, but also referral outside of the country.

Because it will be very difficult for a small island country to have everything inside the country. And we also need to create a Roman standard, how we maximize the utilizations of new technology, digital technology, remote robotics technology. You know, we can do telemedicine, tele-advising, your radiological readings, pathological readings, remote pathological readings. So people can still have access to critical healthcare services remotely. And lastly, which is very, very important, we have to create a norm and standard how to make sure the healthcare resources are there.

If they have experienced healthcare resources and taken by another country, we need to create a mechanism. What are the benefits that this island country would get? Some of the island country are rich, they can get the resources, but some of them are not. We need to have an answer. How we can provide critical healthcare people to support the people in small island country.

Thank you.

CHAIR: I shall now give the floor to Norway to ask the question.

NORWAY: Thank you, Chair. We wonder what do you see as the three most important reforms WHO should undertake during the next five years, and how would you begin implementing them in your first year in office? Thank you.

MR BUDI GUNADI SADIKIN: I have put in my vision and also it strongly I believe as a Member State of WHO, as a health minister, our job is to keep our people healthy so they can live long and healthy. And looking at the change of demographics, looking at the change epidemiologically. Yes, we need to concentrate on infectious diseases, but in many countries, the number of deaths happens from non-communicable diseases. And these non-communicable diseases that create also the biggest burden in every country, pressure for the country budget, is actually can be prevented by, you know, changing the lifestyle, reducing the risk factors, and do regular screening to identify the health issue faster and treat them early. So I would like to spend my time early.

How can we, you know, leapfrog in this management of non-communicable diseases? Because for many countries like myself, I believe if the DG put a lot of attention on this, that will give the biggest impact not only for the people, the quality of the people in every Member State country, but also the budget, the money that will spend in all Member State country. And we can convene and group countries together. Like example, Norway will be different with Indonesia. But maybe similar to Japan because Indonesia doesn’t have an aging problem yet.

Dementia, Alzheimer’s, Parkinson’s diseases, it is the diseases, the luxury of all people. Maybe Indonesia died before we reached that age like in Norway and Japan. But we can group those countries with a similar profile epidemiologically and demographically and spend our focus on how to reduce these non-communicable diseases and also extend the life healthier for all people. Unique by country, under one country, one plan, one budget, or my Accra Reset initiative called it a national health plan. Thank you.

CHAIR: I shall now give the floor to Namibia to ask a question.

NAMIBIA: Thank you very much Mr Sadikin for the presentation. Namibia would like to find out the following: Indonesia led the fight for fair virus sharing during H5N1. As Director-General, would you defend strong legally binding benefit sharing in the PABS annex against pushback from the pharmaceutical industry? Thank you very much.

MR BUDI GUNADI SADIKIN: Yes, I remember my predecessor, you know, shake the world about this H5N1 issues. Ladies and gentlemen, it is my belief that the pandemic will not hit, the big pandemic will not hit only one country. It will hit one planet, what we call Earth. So therefore the spirit of teamwork and solidarity should be there. My second belief, my second belief, when you determine who should live and you should die, that is not up to us.

That is an equal right for every people who live in this planet called Earth. Either he lives in Indonesia or he lives in Nigeria or he lives in Canada or he lives in Australia. So they should have the same right to have access to this vaccine. So, ladies and gentlemen, we had that experience before during COVID. I personally, Indonesia is quite, is not the fastest country to get access.

I knew my African friends because I sit at the board of Gavi. Sometimes it’s extremely difficult for my brothers and sisters there to get access to this vaccine. So this is something that we need to fix. I’m one of, I’m the last health minister that survived during, a G20 health minister that survived during COVID. After the US health ministers.

At that time, I remember global leaders sit together in Bali, and they agreed that first, we need to solve the financing issues. That’s why they established the pandemic fund. Second, we need to solve the access issue of emergency medical confirmation, which is the pandemic treaty, which is the substance is how during pandemic, every Member State of this planet Earth has an equal access, But at the same time, we value the investors that have invented the emergency medical countermeasure, but with a recent return, not with a very abusive return. And pandemic fund is designed to give that compensation. So I wish as the last Mohican, we call it, of the health ministers that attended the 20 biggest economy leaders meeting at that time during pandemic, I wish we can find a solution.

Because while the pandemic fund is there, the pandemic treaty is not there. And the next pandemic is definitely coming. Thank you.

CHAIR: I shall give the floor to Bangladesh to ask a question.

BANGLADESH: Thank you very much, Chair. Our question to the distinguished candidate is that in your presentation, you mentioned that you will try to ensure that stakeholders align their programs with the national priorities. So my question is, how do you try to ensure that? Thank you.

MR BUDI GUNADI SADIKIN: I remember during the COVID pandemic, the first day I become health minister, I have to look for a vaccine and money, money to finance a vaccine. I called WHO and WHO said that we don’t have the money and we don’t have the vaccine, but you need to find the institution called Gavi. And I tried to find Gavi, and Indonesia is not a member of Gavi. And then I tried to look for who is behind Gavi. There is a large foundation, philanthropy foundation.

I contacted the philanthropy foundation, and finally I got access to Gavi. So my experience, this is a very fragmented world from the perspective of a health minister. And then I learned about Global Fund. And then I realized there is SAPI, there is FINE, there is PATH, there is many other global health institutions. And that’s why I insist to myself, I need to become the board member of those institutions.

I put my Director-General and Vice Minister to the board member of those institutions to understand how these things work. And now I’m there, Indonesia also donating money, so I can sit at the recipient country constituent meeting, I can sit at the donor’s country constituent meeting, I can see the difference of perspective and the view that they have, and that is the way the convening power, if I become a DG, that I can do. They have a very focus on the diseases and their mandate. So as a board member, it is my job, and keep doing it, to shift the focus from the country perspective. The National Health Plan, one country, one plan, one budget.

And now it starts happening. The Global Fund and Gavi, we have several joint board meetings to make sure that what can we do to integrate, to make sure that countries are not confused in the different budgeting cycle, different requirements, different audit program, etc. I strongly believe that we can convene these four or five major global science institutions to sit together and then talk with the representative of the country. Who are the key players here? The key players are the donors.

So that’s why I closely work with, you know, great foundations that support them. I work with major countries that are donors like Germany is a large donor. Norway is also a large donor. You know, Japan is a large donor. Because the donors that give the money to this global health institution, they have the power to influence them.

Hey, don’t make it difficult, you know, by focusing on your own interests. But, you know, let’s put the country as the main focus and serve their requests well. Thank you.

CHAIR: I shall give the floor now to Mexico.

MEXICO: Thank you very much. I would like to go back to a question that was put forward to another candidate because it’s so important. As you know, the region of the Americas has an institutional framework which is very specific to our region. PAHO carries out the functions of the regional office of the WHO as an independent organization. And under this arrangement, we contribute financially to the WHO as well as to PAHO.

Now, in that regard, what concrete measures would you implement to make sure that this institutional specificity does not lead to imbalances in the allocation of resources from the WHO and that we are equitably dealt with in line with our public health challenges in our region? Thank you.

MR BUDI GUNADI SADIKIN: I remember as a DG candidate, I was invited to all WHO regional meetings, and I did attend. So I went to Washington, D.C. To attend American region office, AMRO meetings in Washington. The purpose is, of course, to meet with my friends, Minister of Health, and listen for their input and feedback. I’m very surprised that most, several ministries of health left already.

I said, “You’re supposed to have a meeting.” “Yes, I have a meeting, PAHO meetings.” “Oh, you have PAHO meeting?” “Yes, we had PAHO meeting two days before, and now we have AMRO meeting now.” So I said, “Why don’t you attend the AMRO meeting? We attended the PAHO meeting.” “Oh, you have two meetings?” And then the discussion started evolving, and this is for the first time, to be honest, I know that every member of PAHO is different with Indonesia or China. You have to pay two fees and get one benefit. At that time, I honestly asked, do you have two organizations? No, I have one organization that serves the membership.

Do you have two regional directors of PAHO and one AMRO? No, no, we have one regional director. Or do you have two offices? No, we have two offices. Why do you have two regional meetings?

Usually we have one regional meeting, but because PAHO has United States and Argentina in it, so that creates legal complexities. So that’s why, Woody, you came for the first time, we have two separate meetings. So two separate meetings means two additional costs, right? Two additional costs. Before we only have one meeting.

And by the way, everyone, the PAHO member always mentioned to me, we have raised this for the last 10 years. So my brother from Latin America, I don’t want to give empty promises because as a banker, I believe in under-promised and over-delivered. But what I would like to do, when I become a DG, I will sit together with all PAHO members and AMRO members and the WHO secretariat. Let’s see what we can do to fix this. This is a constitutional or charter issue.

This is a legal issue. But for me, as a normal person, it doesn’t make sense. You have one building, one organization, one RD, but you pay two fees. You pay two fees and get one benefit. This is something that we need to work together.

And I promise you when you become DG, what I will do is sit together with all PAHO and AMRO members and WHO secretariat and see. What can we do not in 10 years but hopefully one year two years or three years thank you

CHAIR: I shall give the floor to Barbados to ask a question.

BARBADOS: Thank you Chair. Caribbean SIDS face increasing threats from hurricanes, extreme heat and other climate related hazards which place considerable pressures on healthcare infrastructure. Should you become DG, how would you strengthen WHO’s support for climate resilient health systems, incits, climate health financing, resilient healthcare infrastructure and emergency preparedness whilst ensuring that the particular vulnerabilities of Small Island Developing States are reflected in WHO’s strategic priorities. Thank you.

MR BUDI GUNADI SADIKIN: Yes, I can say to you that I have the same feelings like my friend in Barbados. Because as I mentioned before, Indonesia consists of 7,000 inhabited islands and some of them are extremely small. And we share all the climate related emergencies, except Indonesia is very lucky that we don’t have hurricanes. We don’t have hurricanes because we are in the equatorial principle. So as a DG of WHO, I would like to make sure, as I mentioned before, that we need a special focus, a special team dedicated to discuss about these small islands.

Because they have a very unique health issues. Issues. As an EDG, I will make sure that, you know, at the forefront, your primary healthcare needs to be equipped, need to be strong. So if that is, you know, healthcare emergency, they are the fastest way to take care of your people. Second, we also have to make sure that And the referral network is well established.

Because if something happens, then you need to carry the patients to the nearest capable institutions. And it’s impossible, like in Indonesia, that we have hospitals in every island. Because sometimes the populations are very, very small. So we need something new, transportation methodology agreement, pre-signed agreement with the healthcare provider, etc. And number three, we have to use technology.

With the advancement of digital technology, with the advancement of telemedicine, robotics, remote robotics technology, there are many things that we can do with new technology. So this team consists of many Member States coming from small island development country need to design a healthcare ecosystem for the small island development country. And especially, I also mentioned before, we need to make sure the peoples there are ready. We need to train them. We need to develop them.

We need to have a proper arrangement. How to export healthcare services out, how to import healthcare professional in. So we make sure that anytime there is a crisis, then people are there. You know, about the financing, I would be very, very happy to convene the more powerful institutions. I knew the president of World Bank personally, president AIIB personally, ADB, you know, and also Islamic Development Bank personally.

So we can create something that during emergency, the fund can be withdrawn quickly to serve you. Thank you.

CHAIR: I shall now give the floor to United Republic of Tanzania to ask a question.

UNITED REPUBLIC OF TANZANIA: Thank you Chair for giving us the floor and thank you Mr Budi for your presentation. The Development Assistance for Health has reached only half of its 2021 peak. The recent estimates predict that the numbers are dropping. This happens at the time when many countries are still struggling to finance their national health plans. How would you use your convening power, if elected, to support countries financing their plans, especially by calling partners from within and outside the country?

MR BUDI GUNADI SADIKIN: This is the topic of the WHO Member States everywhere across the world. How can we sustainably financing our healthcare programs? And that’s why during the meeting in Africa as a co-chair of Accra Reset, we are discussing this in quite some depth. And we had an understanding that what we need to do is to make sure that domestic capability of financing capability of every country is being established. At that time, WHO also running the Joint Task Force for Global Health Reform, which is one of my friends from Germany, Mr Bjorn, is sitting here with my friend from China.

So Mr Dong Feng. So they are sitting here. And this is, I believe, the best landing point for the Accra Reset result to be adopted. So it will be supported legally by all of the countries. They have some credibility.

And the focus is, many people talk about the focus, how to finance WHO. But when you talk to the Member State, the focus is how to help the Member State fund their healthcare program effectively. Indonesia, fortunately because my previous connections, we got funded. As I mentioned to you, in the last five years, more than $8 billion. I remember at the time, one of the source of funding is from Asian Development Bank, $1 billion.

Asian Development Bank head office is in Manila. So I met with my colleague, Herbosa, the Minister of Health of the Philippines, asking, Budi, how did you buy 10,000 x-rays and ultrason across your 10,000 primary health care clinics? I get money from ADB. How much money did you get? One million.

Why ADB head office in Manila and only get 100 million of them? I mean, I can’t help you to write a good proposal as a banker and to justify and make a call to the president of ADB, which is located in Manila. And six months after that, the Philippines health minister received 1.2 billion. And he is very proud because he received more money than I do. But that is something that I’m doing.

I’m now working with Egypt, with my friends in Egypt, because they want also to reform the healthcare institution and get money from World Bank. And the World Bank asked why you follow the Indonesian rule. So ladies and gentlemen, money is there. We are not lack of money. It’s a matter how the health minister can build one national health plan.

Talk with the Ministry of Finance, that is the most difficult. Get the agreement and then go to the source of funding and get it done. And as a DG, I will help you to do it. Thank you.

CHAIR: Since we added 20 seconds, we will take one more question. I shall now give the floor to Japan to ask a question.

JAPAN: Thank you Mr Chair. Universal health coverage, which is to ensure quality and affordable healthcare for all, remains the key shared global goal. Yet many countries are facing severe fiscal constraints. How do you believe WHO should support countries in achieving and sustaining UHC, including through strengthening sustainable health financing. Thank you.

MR BUDI GUNADI SADIKIN: Favorite questions to an ex-banker of the financing. And I can share with you, this is not only happened with WHO, but also happens in other United Nations organizations. It happens with Global Fund in the last replenishment, happens also in Gavi, where I sit at the board. But what I would like to share with you is again, the money is there. How can we structure our proposals, requests, great natural health plan, and get the good access to the right source, and we can get it, and we can get it.

So, Japan is very advanced in helping countries, Because I was involved in the USC meeting and knowledge hub in Japan, how to make the two world institutions sit together, the World Health and the World Bank. World Health make you healthy, World Bank make you wealthy. And I can tell you as a 30 years banker, health is the best wealth in the world. However rich you are, if you are not healthy, that means anything. That’s why it is my purpose as a DG, if I become a DG, I will make sure that all health ministers, especially for lower and middle income country, have a good access how to translate the national health plan into something that can be understood financially.

And that is very difficult for health ministers. Because every time I spoke to my fellow minister of finance, I said, what is this health minister talking about? You know, investment. But they are talking about billions of US dollar investment. What are the returns?

So those are the things as a DG that I can help you. And I can convene, you know, experts for many global development banks that are ready to help. Egypt is one example. They’re ready to help Egypt. And we just have to convene the right people to help them.

By the way, Japan is very famous for the most number of centenarians above 100 years of age. Why? Because they live healthy. And with the joke from our chair, I realized also Nepal can reach as many as Japanese, not only to make them healthy, but also to make them happy because he always gave jokes in this meeting. Thank you.

CHAIR: Thank you. The time allotted for the question and answer is now exhausted. And so is the total time allotted for the interview. I wish to thank you, Mr Sadikin, for being with us today. And I would ask the Secretary to accompany you out of the room.

While the Secretary is accompanying Mr Sadikin out of the room, and Dr María P. Nera is being brought in, I would like to ask the delegations to remain in their seats too so that we may begin the next interview as soon as the next candidate is here. Vielen Dank. This is the short way. Please, please take your seats.

Good morning, Dr María P. Neira. Welcome to the First Candidates Forum for the election of Director-General. I wish to thank you for coming to this interview today. I understand that the Secretary has already informed you of the way we shall proceed this morning, and I propose that we start immediately with your oral presentation.

You have the floor. The 10-minute period will begin simultaneously with the activation of the lighting system.

Interview of Dr María Neira

DR MARÍA NEIRA: Thank you very much, Chair. Ladies and gentlemen, distinguished members of the EB, Member States, buenos dias. Bonjour tout le monde. Good morning, of course. Ladies and gentlemen, those are bad times for multilateralism.

Geopolitical tensions are making cooperation harder and public trust is fragile. At the same time, biotechnology and artificial intelligence are opening new possibilities, yet millions still lack essential care. Some countries are aging rapidly, while others have growing young population. Emerging infections, threats, and climate change are adding to the challenge. Yes, the situation is very serious, and it will be responsible not to recognize it.

WTO is part of this very serious situation, but I think we need to remember what we are here for. We are here for something which is a marvelous mission, global health. And I think because of that, we need definitely a radical change, a radical reform of our governance but at the same time we need a positive agenda. So where do we start? We start with people.

The best of WHO is its people. We must focus on delivering our powerful mandate. That takes highly qualified, motivated professionals who are recruited and promoted on merit. It also takes integrity in every level in a working environment where people can do their best work and feel safe speaking up. I know something when headquarters, regional offices and country offices work together as one WHO, we can move mountains.

Let me start then with some recommendations that I think will be part of this positive agenda. Let’s start with science. WHO is the best when we turn science into norms and standards and recommendations that countries can use. And that is why I think it is very important to align, and this will be one of the first positive agenda items, align the office of the chief scientist with the regional and country experts, working with the WHO Collaborating Centers and the health professionals together with the Science Council. We must assess the evidence rigorously, update guidance quickly, and keep scientific conclusions independent of political pressure.

Another one, people should be able to see where WHO is present in their daily lives. Each guidance helped shape drinking water standards, childhood vaccination programs, and smoke-free public spaces. So we need to make sure that all of those stories more often are communicated in a very plain language. The work is already underway to rethink the global health. We need climate resilient low carbon health systems, the ones that are fit for the 21st century.

We need to use the global health architecture as an opportunity. WHO should be at the center of the global health systems. Governments should be set in their priorities and lead implementation, and WHO should bring partners together around one national country-led plan. With clear responsibilities and shared results, global health funds and development banks can help countries finance delivery. We need a sharper WHO with fewer priorities.

Each pursued well and every dollar traceable to a result in our country. I know this organization very well, and this allowed me to know where to cut on a surgical way, but protecting those who are really at risk. Finance. WHO’s authority has never come from the size of its budget. WHO’s authority comes from evidence.

And my first responsibility as a DG is to get the greatest possible health impact from the budget that WHO has today. I will pair fiscal discipline with country sovereignty and implementation, moving resources closer to countries, reducing parallel structures and measuring delivery against results that matter. I support raising assessed contributions to 50% of WHO’s based budget by 2030, and I will work to broaden our donor base. I will make the case that finance ministers, in their own language, they need to receive the health arguments to invest, understanding what can it save, who will benefit and how soon. And I will work with multilateral development banks to ensure health gains count when they assess investments.

But the strongest case for renewable investment is a WHO whose science is trusted, whose work addresses the health problems people is facing, and whose results are visible. Alongside the question of what WHO can found, I want to ask another question. What can WHO influence? Medicines will save lives, but public health must also change the conditions that put lives at risk. And that’s why it means by making health the compass for a changing world.

And it is why I want to put primary prevention at the center of the health priorities. Mayors might not have control over health budgets, but their decisions on transport and street design can cut air pollution, and that means health. Decisions about food, agriculture, energy, and housing also shape people’s health. WHO can bring evidence to the people making those decisions while there is still time to shape them. Primary prevention reduces vulnerability before a crisis hits.

Safe water and sanitation help prevent cholera and other infectious diseases. Climate resilient low carbon health system can keep the essential care available through floods and heat waste while reducing emissions. As science expands what we can prevent, we must take care of those advances to reach the people who need it. The same ambition applies to cancer, heart disease, stroke, diabetes, and chronic respiratory diseases, because we know how to reduce many of the risks causing those diseases. Primary prevention is essential to keeping health systems sustainable as the burden of non-communicable diseases is growing.

Make sure that science serves every country. Ladies and gentlemen, why do I want to lead WHO? Because there is no other platform where you can have such an incredible impact on people’s health. Because I’ve been working on clinical work, I’ve been working on emergency humanitarian settings, I’ve been at the government driving and creating reforming from an idea on food safety, creating an agency, an Spanish national agency on food safety and nutrition, responsible for thousands of inspectors, national academies, centers of expertise in 17 communities. I know how to transform an idea into a reality and results.

I believe in this organization and they are telling me that I don’t need to say anything about my passion because this is quite obvious when I talk. It’s a very fair question if you ask why me. I think you need to ask yourself why me. Well, I think I have demonstrated the background, the experience working at a global level, spending five years in Africa in places where the conflicts were affecting the most vulnerable populations. I grew up as a public health expert in refugee camps in Central America.

I speak five languages, and I am very much convinced that this organization we have together, we have gold in our hands. [In Spanish] Y es necesario para nosotros transformar ese objetivo en el mejor impacto posible en la salud de la gente. Como Martin Luther King, él decía: “Tengo un sueño”. Tengo un sueño también. La diferencia es que tengo un sueño apoyado por un plan, una visión, un equipo que lo implementará y una manera de medir todos esos resultados que resultarán de ese sueño.

[Editor’s translation: And it is necessary for us to transform that objective into the best possible impact on people’s health. As Martin Luther King said, “I have a dream”. I have a dream too. The difference is that my dream is supported by a plan, a vision, a team that will implement it and a way to measure all the results of that dream.] But let’s dream together because attaining the highest possible level of health for our people is much more than a dream. Thank you very much.

CHAIR: Thank you. We will now continue with the questions and answers. I shall now invite Member States and Associate Members wishing to ask candidates a question to place their purple token in the receptacle corresponding to their region. May I please ask the Secretary to collect the tokens to display the relevant token on screen. I shall now pull one token from each receptacle following the order of regions previously determined, starting, therefore, from the Southeast Asia region.

Once six tokens, one per region, have been pulled out, I will invite the corresponding Member States or associate members to ask a question. Thailand Namibia. Egypt. Colombia Norway China. The six members that will be given the floor to ask questions in the sixth round are Thailand, Namibia, Egypt, Colombia, Norway and China.

I shall now give the floor to Thailand to ask a question. The 50-minute period will begin simultaneously with the activation of the lighting system.

THAILAND: Thank you, Chair. Dr Neira, you led WHO’s work on climate and health for two decades. Your vision puts prevention at the centre and makes health the compass for a changing world. But in most countries, climate and prevention still sit in separate programs on the edge of health systems with their own funding and staff. Healthcare and universal health coverage rarely reflect them.

How would you make climate and prevention the foundation of primary healthcare and UHC, rather than separate programs? And by 2032, what change would show that health has become the compass for decisions on energy, for cities and transport. Thank you.

CHAIR: Dr Neira, you have the floor now.

DR MARÍA NEIRA: Thank you very much, Representative of Thailand. It’s true that I have been working for almost two decades on issues related to environmental health, putting a lot of emphasis on making sure that everybody will understand that environmental risk factors can represent an opportunity to prevent mortality and morbidity by 25%. So we could reduce an incredible amount of millions, around 13 million deaths every year, if we invest on addressing those environmental risk factors. Climate change came to undermine all of those pillars that we have been putting to protect our health. When we started in WHO to work about climate change, the first step was to demonstrate that we needed the evidence to proving that climate change was eroding all of those pillars of health.

The air we breathe, the food we eat, the water we need, the shelter, it was forcing population to be displaced. So we put the evidence saying the climate crisis is a health crisis. But that was not enough, obviously. We have the evidence. We needed to go to the places where we could influence with that evidence, influence the policies that were needed.

And we started to influence on adaptation, making sure that our health systems will be better prepared to cope on how climate change was affecting already the capacity to deliver health at our health centers and health system. So adaptation to climate change is nothing else than reinforcing our primary healthcare by having better vector control, by having access to water and sanitation, by having epidemiological surveillance, by training our own health people and making our health system more resilient. On the other hand, Then we started to try to influence policies to mitigate climate change because by mitigating the causes of climate change we were obtaining massive health outcomes. One of the most classical examples is air pollution. If to mitigate climate change you need to reduce the sources of gas emissions, you will be reducing air pollution and by doing so you will contribute to reduce the seven, more than seven million deaths that we have every year due to exposure to air pollution and climate change.

So yes, climate change needs to be really at the core of all the operations in WHO because our health system, other ways will suffer. We need to be better prepared and we need to influence others in order to incorporate the benefits for health that those interventions can generate. Thank you.

CHAIR: I shall now give the floor to Namibia to ask a question.

NAMIBIA: Thank you very much, Chairperson, and thank you, Dr Neira, for your presentation once again. Many developing countries like Namibia have weak laboratory systems which remain very urgent. How would you balance your prevention agenda with the treatment, diagnostics and health systems needs of high burden countries? Thank you, Doctor.

DR MARÍA NEIRA: Thank you very much, Namibia. When we look at health, we need to look at providing care. Obviously this is one of the best responsibilities we have. We need to treat our patients, so we need to equip our health system, our health care facilities with diagnostic capacity, with epidemiological surveillance, with trained staff, health workers which are so important. Infrastructure.

I’m still shocked that unfortunately in some places, I’m afraid in Africa as well, some healthcare facilities do not have access to safe water and sanitation. My mantra on that has been saying that we should not have a single healthcare facility without access to safe water and sanitation because then we cannot provide services similar for electricity that we can provide with the solar panels. Maybe that will be another part of the importance of reinforcing the capacity of our healthcare facilities to provide care. But it’s true as well that we need to have prevention. So the two are not in contradiction.

At the contrary, at the healthcare facilities in particularly and settings with limited financial resources. A good investment means making sure that your patients arriving to the healthcare facility will not have stagnant water outside the healthcare center because that might attract the mosquitoes that will transmit the diseases that then you are trying to treat. You need to have laboratory capacity, so a minimum package of resources and facilities that will give the whole package of what prevention and care for our health care facility means. But another good point to support the health care facilities when they don’t have the resources and as you say we need laboratory, we need diagnostic capacity, we need better training is to mobilize other partners, other partners maybe from other sectors that will collaborate and WHO can be one of them. WHO can support and define what is the best and most adequate package of interventions at the healthcare facility, how to better use the resources that normally are very scarce, and as well mobilizing other donors with this idea now of sovereignty and making sure that the country will decide and the country will have all of those supplies provided that the country define those as a priority.

Thank you very much.

CHAIR: I shall now give the floor to Egypt to ask a question.

EGYPT: Dr María. Good morning. You have spent decades at WHO linking health to climate, air quality and environment. EMR region faces extreme heat, water scarcity, dust storms and environmental damages from conflict and for sure with direct health consequences. How would you move these determinants from the margins of the WHO’s work into its core in a manner of measurable outcomes for countries of my region and how would you secure real commitments from energy, water and agriculture financing systems which sit outside health ministries.

Thank you.

DR MARÍA NEIRA: Thank you very much for this question. That will allow me to elaborate a little bit more on what do I mean by the work of WHO on influence. When the mayor of London put in place an initiative to reduce traffic, what is called the ultra-low emission zone, it was not a very popular measure, but four years later we realized, and I say we because we did the scientific assessment, it was a reduction by 40% on the mortality caused by exposure to air pollution in London capital. When we, as WHO, we attend the meetings on energy, it’s just with a message and say, well, the type of energy the countries use at country level will determine the quality of the air we breathe. And part of this very scarce budget that we have normally on prevention, normally the budget on primary prevention as you know in general goes around between 3 and 7 percent, but in order to scale up this budget for primary prevention we need to bring the funds from other sectors.

The way to do it will be to define a catalog or a narrative of the health outcomes that you can obtain if you are the Ministry of Agriculture, the Ministry of Energy, the Minister of Environment, the Ministry of Infrastructure. We will prepare a package of health arguments to measure the health outcomes you are obtaining and then using this narrative to push them to advance in these sectorial policies that are so critical, so important for health and the ones that will reduce the need for our own budget as health or as WHO Global Agency on this primary prevention. It’s more about influencing other sectors, convincing them by the health outcomes of course, we need to give them the result of those interventions because sometimes they can use it back to get support by their citizens. But we need as well to communicate more about science. We need to be the best organization together with other institutions on scientific evidence, but we need to be as well able to communicate with our citizens on a more daily way, explaining to them why WHO is so important on their daily lives.

And by doing so, we will bring back this interest and love for this organization that we all need to revitalize. Thank you very much.

CHAIR: I shall now give [the floor to] Colombia to ask a question.

COLOMBIA: Thank you very much, Mr Chair, and thank you very much, Dr Neira. Given all of your experience that you have had in public health and humanitarian settings, equitable access to technologies, to health technologies, continues to be a great challenge for developing countries, especially in rural areas as well as communities that have been affected by conflict and displacement. As the Director-General, what concrete measures would you promote to facilitate effective technology transfer as well as strengthen national capacities of research, innovation and production, guaranteeing that this progress is beneficial to the most vulnerable? Thank you very much.

DR MARÍA NEIRA: [Interpretation from Spanish] Thank you very much, Colombia. Thank you very much for giving me the opportunity to speak in my own mother tongue, in a language that I love, and I think that it is a beautiful language. I hope that you are all convinced of this. All languages are beautiful, but Spanish is really one of the most beautiful, I believe. Yes, clearly the role of the WHO.

Well, first of all, let me start with the end, your last question. What does this transfer look like? What does this reform look like within the WHO? What kind of reform would we like to do alongside this global health architecture reform, the global health architecture that we belong to? What we would like to do, and what Accra Reset is saying, the Lusaka agenda, all of these documents, the documents of the European Union as well, what everybody is saying, where there seems to be an enormous convergence, is in the sovereignty of Member States, in drafting national plans, which is really a unique national plan, where afterwards donors and partners can align themselves and contribute to these national plans.

And this is where we have convergence, and this is where technology plays an important role. The World Health Organization can contribute to speeding up this transition towards this sovereignty. How? Well, by training healthcare personnel, by transferring the financial resources as well as skills, by helping as well to understand how these technologies can help and how to make it more accessible. Not to just transfer technology, because this is not exactly the role of the WHO, but to make sure that people have access to these different types of technologies.

The role of regional offices is absolutely crucial as well. This role would also be reinforced by the regional offices. They need to make sure that they can help with the regulatory capacity and bolstering it at the regional level and also look at how we can improve manufacturing, production. We can also have a coordinating role at the regional level and help to make sure that access technology is provided for public health right now. It is absolutely critical.

What does artificial intelligence mean? What impact will it have on health? What impact will telemedicine have? What impact will technologies have on health? This is where the WHO can play this role of increasing access to technology and by coordinating all the different efforts and partners, organizations, members that can help speed up this autonomy and sovereignty at the national level.

Thank you very much for your question, Colombia.

CHAIR: I shall now give the floor to Norway to ask a question.

NORWAY: Thank you. We need to reform WHO due to financial restraint and to secure the top priorities. In that regard, what do you see as the most important internal reforms WHO should undertake during the next years, and how would you begin implementing them in your first year in office? Thank you.

DR MARÍA NEIRA: Thank you very much. Clearly, thank you Norway, the reforms that we need will benefit enormously from the Global Health Architecture Task Force, from the Accra Reset and all the opportunities we have now to look at all of those recommendations. I say that the sovereignty looks like it’s one of the areas in which everybody agrees and as well the fact that we need a radical change in many things. My radical change the first year I think is creating a very one WHO with the three regional and country offices, is a very well aligned collegial strategic in terms of global health, very strategic. Another reform I think is on the Chief Scientist Office.

I will align it across the organization as well to make sure that science is very much respected. We bring back trust and we put in place all of those mechanisms. I think we need another reform which is quite important, it’s about the internal justice, and that’s something that we need to address quite quickly, providing the resources, making sure that we give the priority that we deserve, and setting the sample as well, because it’s absolutely unacceptable, the fact that we have a backlog of cases. So I will start again by the end, looking at the country level, selecting countries where the WHO staff working at country level, we will prepare them to support that idea of one national plan. We will offer ourselves as leader to implement the recommendations that will come from the Accra Reset and the Global Health Architecture.

I hope that those recommendations will be endorsed. And if I am the Director-General of WHO, my commitment will be to put those recommendations quickly, effectively and pragmatically without going into yet another very destructive movement internally. Is more on radical changes to bring back our scientific credibility, understanding how we will communicate outside the fact that WHO is needed and is very relevant for our lives, and of course this alignment and the better use of the resources, efficiencies, that is one of the priorities in the first year. So if you judge me after one year, I I will ask you to judge me on efficiency on the resources, setting the tone for a culture that is more creative and respectful, and of course aligning the resources of the organization to be ready to move mountains, as I said before. Thank you.

CHAIR: I shall now give the floor to China to ask a question. Will you speak in Chinese, which is one of the most beautiful languages as well?

CHINA: Thank you, Dr Neira. Our question actually is closely linked to the former two questions. You stressed that through influence, we can mobilize energy and agriculture sector and other sectors to jointly serve healthcare. If elected as the DG of WHO, how can you, against backdrop of limited resources, better contact those kind of mobilization work. So as to let other sectors jointly move forward the health related objectives and goals.

Thank you.

DR MARÍA NEIRA: Thank you very much, China. And I’m really sorry that I don’t speak your beautiful language. I’m happy to see that this is a contest to see which have the most beautiful language. All are absolutely, the important thing is that we can communicate. That’s the important thing.

Very thoughtful question. If I understand correctly, you want to know how we can influence those sectors with the limited resources we have. And maybe allow me to say something that I saw in your own country. There is a slide that I use very much on my presentations where your Vice Minister of Health show that the GDP of the country was going up while air pollution was going down. So I think this is very relevant because in some of the changes we need to influence the energy sector, for instance, or the transport sector, they argue that there is an economic obstacle to that, while we can prove the contrary, that if you influence that policies that will aim at reducing air pollution, the health benefits and therefore the costs will be clearly very much reduced.

How do we influence that with the limited resources? Well, this is something that will require to incorporate this approach of primary prevention into any of the programs we have. When we talk about non-communicable diseases, non-communicable diseases, everybody talks about access to treatment, of course care, all the new technologies, and addressing the behavioral risk factors. Well, I will argue that if we want to prevent non-communicable diseases, and if you look at the global burden of diseases, you will see that one of the biggest risk factors for health is tobacco, high blood pressure, and under that is air pollution. So, our intervention will require simply, once we have the evidence, package that evidence into health arguments that then we can use and we can measure.

Yes, it will take some thinking and structure to prepare that package of interventions and health arguments, although for most of those interventions we have it already. Is more taking it and collecting it. The problem with primary prevention is that normally we do not measure the results, the health results when are obtained because you don’t see it any longer, the risk. So we need to change that narrative and make sure that we give glory and benefit and recognition to those who are obtaining health benefits from interventions in different sectorial policies. So, my answer in short is that this will not require a big amount of financial resources at all.

Thank you.

CHAIR: The first six questions are read and answers given. The lighting system tracking 50 minutes Spirit will now be paused. I shall now ask the Secretary to merge the contents of the six receptacles into one and will continue with the selection of Member States or associate members until the time available is exhausted. Each time a question is posed and an answer is provided, the lighting system will be activated to track the one-minute period for the question and the three-minute period for the response, respectively. I shall now give the floor to Poland to ask a question.

The lighting system tracking 50 minute period for the question and answer session will be reactivated at the same time.

POLAND: Thank you. Thank you for the presentation. Our question is the following: Based on your experience within the WHO, which elements of its current organizational structure work well, according to you, and which would you change as Director-General? Thank you.

DR MARÍA NEIRA: Thank you very much for the question. I’ve been working on this organization for a while and I think I saw the organization at best and some of the weaknesses as well of the organization. But clearly, the organization and the mandate continues to be one of the best missions we can engage on it. What are the structures that work well? I think science, whenever we, the convening function, being able to call all the experts from around the world, convening them to look at any health issue that we need to address.

This is one of the most important structures or capacities that we need to maintain as a major priority. Obviously, the health staff in this organization, we produce intellectual recommendations and policy recommendations. So the idea is how our guidelines, our famous guidelines, are going to the end, are going to the end in terms of influencing. And this is where maybe we need to enforce a little bit. If I am Director-General, I will make sure that we go until the end and align in the three forces of the organization.

No other organization has the power that this one in the mandate we have. We have offices in many countries. We have regional offices. We have headquarters. So if this One Health, One WHO is well aligned, we can definitely use our resources in a very impactful way.

So this is another structure that we need to reinforce, but again, having a common strategic direction, common objectives, and aiming at supporting the countries while we take care of the global issues that will require as well the support of the countries. Many infrastructures here that needs to be protected. I think all the… What makes us strong on anticipating the new risks. WHO is not just about treating with the diseases that we know.

We need to anticipate what is next. What about microplastics for us? What about electronic waste? Will impact our health. So we need to create probably something that will reinforce that through our scientific capacity.

But that can be done relatively quickly on radical surgery, but surgery that is not blind, but is precision surgery. Thank you very much.

CHAIR: I shall now give the floor to Indonesia to ask a question.

INDONESIA: Thank you, Chair. Thank you, Dr María, for your presentation. Is investing in digital health and sees AI as a powerful tool to improve care if it is safe, trusted and accessible. You states in your campaign that innovation must be governed in the public interest and translated into access, not wider iniquity. If elected as Director-General, what concrete role WHO should play in governing AI in health so that it benefits reach all countries rather than widening inequity while ensuring the protection of health data.

Thank you.

DR MARÍA NEIRA: Thank you very much Indonesia and thanks for this question that is really AI and digital are one of the defining issues of our time so it will be irresponsible for WHO not to be on top of, as you rightly say, governing AI for health and digital for health. I think there are several efforts that are already going on where WHO and parties and partners, we need to look at what this new technology will bring to our health, to our global health. But more importantly, how we will work with data, for instance, how will we protect data privacy, how we will make sure that we will address and make easy access for digital medicine at the healthcare facilities at remote areas for instance, but making sure that this will represent a health advantage for them. In some places where we want to bring this health technology and the digital medicine, they do not have electricity. So I think we need to address that as well, to make sure that everybody will have access to electricity in order to benefit, as one of the key issues for the access to these technologies, in order to benefit from digital medicine.

But again, providing advice, defining the benefits for health and defining as well how this investment will benefit and the cost benefits for that in certain places where they need to receive that. At global level, I think we need to put in place a global strategy, a global frame to look with those who know very well about this. I understand we have expertise already in some regions in the house, so putting a global framework to look at what artificial intelligence and digital medicine can represent for the health of our people and particularly accelerating access for those countries who might have more difficulties to reach it. Thank you very much.

CHAIR: I shall now give the floor to Uganda to ask the question.

UGANDA: Thank you, Chair, and thank you, Dr Neira, for sharing your vision and priorities. As you are aware, negotiations on the PABS annexed to the pandemic agreement did not produce a final text recently at the ninth meeting of the Intergovernmental Working Group. Countries like mine expect the PABS annex to establish a legally binding predictable benefit sharing system. As DG, in the event we do not have an agreed text, how will you facilitate moving the negotiations forward, promote equity to ensure that countries like mine have access to therapeutics and that when we have pathogens we can share the benefits equally. Thank you.

DR MARÍA NEIRA: Thank you. Thank you very much. And I really hope that remembering May 2025 in this room, or maybe in the, no, in this room, it was such a spirit of celebration and everybody was very happy because the pandemic treaty passed one part of that. And I remember those pictures, those images of all of you Member States celebrating the fact that you have reached an agreement on certain parts of the pandemic treaty. Well, I will really love as a DG to see that spirit again as soon as possible, maybe May next year, when you will be approving this annex that is creating now those differences.

What can I do as a DG? Of course, the decisions will rely, the negotiations will rely on the Member States. He says the governments are the one deciding and WHO is the one advising. But I think that the secretariat needs to be respectful and respecting your independence, but not necessarily passive. I think we can offer an environment where we can help you with technical advice, maybe different scenarios, maybe facilitating different platform discussions, maybe reinforcing the technical capacity that you need in order for you to take informed choices.

And this is what I will do as Director-General, understanding myself very well where the blockages are, where the obstacles are, and then creating the mechanism for you to choose, but to choose on the best possible conditions with the best possible technical assistance provided and maybe even providing you some scenarios or platforms where those issues between the Global South and others can be properly addressed and hopefully in May 2027, having again a big celebration here and pictures all in the social media, people celebrating that the Global community celebrating that we have a treaty that will help us to be better prepared, responding better, having access for all the countries and respecting the vulnerabilities and the difference among ourselves. Thank you very much.

CHAIR: I shall give the floor now to Italy to ask a question.

ITALY: Thank you. The rising burden of mental health conditions among young people calls for a progressive transition from systems focused on treatment to models prioritizing prevention and promotion of mental health. How do you believe WHO should support countries in addressing determinants of mental health, strengthening protective factors such as social connection and protecting youth voices and consent in order to reduce the risk of onset of mental disorders among young people? Grazie mille.

DR MARÍA NEIRA: Even if Italian is a beautiful language as well, I’m afraid we cannot speak Italian here. So thank you very much for the question. And when I talk about non-communicable diseases, I should properly say non-communicable diseases and mental health. And I was, a few months ago, I was attending a meeting on very developed countries where the ministers of health were saying that one of the biggest health challenges they have is about the fact that the teenagers, they don’t have enough sleeping hours because they are in front of those screens. And that was becoming a real public health issue.

We have the social media. We have the isolation of the young people. My generation used to play outside. Our generation, I think we can all say that, all of our generations, we play outside. We have more interaction with other people, real interaction, more social life.

These days, I’m afraid the issue of very young people suffering from mental health problems is becoming a major, major issue. WHO should work, again, through science. Mental health has to be one of the pillars of all the approaches we have for non-communicable diseases. Looking at, again, the primary prevention of mental health, we need to see how all of those social media, the isolation, the screens time that we spent in front of them is definitely recommended or not. In some countries, as you know, they are even going very far on making public health recommendations about not using those screens, I mean social media until a maybe we need to explore all of that, and clearly making true experts and then scientific advice recommendations on what are the new approaches to these big challenges that mental health represent, particularly for the youth.

I remember when Dr Brundtland came as Director-General, she was the one who put that very high on the agenda of WHO for the first time the issue of mental health, And I think we need to, we have it on our agenda already, but I think as a Director-General that I will give a big priority to this issue of mental health. And we need to understand as well what is happening with all of those neurodivergences that we are seeing these days. And I think these deserve more research as well. And serious one, rigorous one, not certain statements that are going around. So, thank you very much, Italy.

CHAIR: I shall give the floor to Zambia to ask a question.

ZAMBIA: Thank you, Chair. Good morning, Dr Neira, and thank you for your comprehensive presentation. We have noted that immunisation coverage has stagnated across multiple antigens, including DPT3, measles and many others. If elected as DG, how would you improve coverage of the coverage in developing countries. I thank you.

DR MARÍA NEIRA: Thank you. Thank you very much, Zambia. You know how much I think that this organization should focus on primary prevention, so therefore, vaccination is one of the key pillars of that. There are many reasons maybe why we are stagnating on the vaccination coverage, but probably one of them is the fact that those fake news that are really eroding the credibility of the vaccines, particularly after COVID, is reaching as well other countries. What do we need as WHO is to work with the partners, most of them here in Geneva as well, Gabi particularly, to make sure that we lead the assessment of this situation, the access to those vaccines, and making sure as well that we address the reason why those vaccine coverage targets are not reached.

I think as well it’s a question of, as I was saying previously, how we communicate to our communities, this whole, we make them again come back to WHO for technical advice, for scientific advice, for the recommendations on all issues that are related to public health and vaccination being one of them. We need to communicate, we need to keep with those good programs, we need to align our forces with all the partners involved in vaccination and particularly with you countries to make sure that we make it because our vaccination programs are one of the most powerful public health tools that we always had. Thank you.

CHAIR: I shall give the floor to Chad to ask a question.

CHAD: Thank you very much, Mr Chair. Good afternoon, dear doctor. In your presentation, I’m here just in front of you. In your presentation, I noticed that the first words you used in the first sentence was multilateralism. We know that today, multilateralism is not doing as well as we’d like and even less so in WHO.

What do you plan to give trust back to Member States? It’s all about trust but also to associated states. Thank you.

DR MARÍA NEIRA: Thank you very much Chad for this question. Yes true. I started by saying that multilateralism is suffering but we must also try to restore it. Everybody who works here we’re very much convinced about the importance of multilateralism. How can we restore this trust?

It’s not just by saying we need to ensure multilateralism or believe in WHO. We need to restore trust in multilateralism and to do so we need to prove that we have good results through multilateralism. And we need to have a campaign. We have to explain to people why multilateralism is important. It’s not just because there are meetings and international organizations.

We need to get closer to people and give them a list of the results we’ve obtained, positive results that have been beneficial for them thanks to multilateralism. We need and we need to convince and also be positive. We can’t just say we abandon multilateralism or we should criticize countries that do so. I think we ourselves must all together try and create the reasons why, well, if there is a country, institution or a person who doesn’t believe in multilateralism, Well, we need to understand how to convince them, what reasons we will give them, and the best reason we can give them is, well, our results. Everything will obtain, and we’ve obtained, and this is how we will motivate them to come back to multilateralism, when we explain to them what we’ve achieved thanks to the influence of multilateralism, and thanks to this power, this unity.

And I do agree with you, it’s not going to be easy at all. But multilateralism must be one of the most robust pillars of this organization there is no doubt about it. So I count on Chad to help us here. Thank you.

CHAIR: I shall now give the floor to Barbados to ask a question.

BARBADOS: Thank you, Chair. Caribbean and other SIDS remain heavily dependent upon imported medicines, vaccines, diagnostics, and medical supplies, leaving them vulnerable to supply chain’s disruption. If elected Director-General, what concrete steps will you take to support PAHO and other regional pooled procurement, regulatory strengthening, technology transfer and sustainable local regional production of essential health products, ensuring that small countries can achieve greater health security and equitable access. Thank you.

DR MARÍA NEIRA: Thank you very much, Barbados. I have the privilege to work very often with the SIDS, the Small Island Developing States and particularly with Barbados. I remember a big meeting we organized on looking at two of the issues that are challenging the SIDS and in particular Barbados, non-communicable diseases, the rise of non-communicable diseases and mental health and climate change affecting and creating a massive vulnerability for those countries. I will answer saying that clearly part of the response to your question comes to the fact that we need a regional collaboration. And this regional collaboration is where WHO region can help to provide the tools for establishing this regional collaboration.

Pulling supplies is a way to make sure that you are less vulnerable. By adding efforts and creating this regional solidarity and pull procurement, I think you can reduce that vulnerability. We need to then look at, as the WHO, what do we need to ensure that? But what are the capacity that the countries might need to create that capacity at country level and at regional level to move quickly on this pooled procurement. I think as well that the pandemic treaty annex, the day you will sign it, and I really hope that you will, will provide provisions for supporting this pooled procurement, for supporting this pre-qualification manufacturing issues that are relevant for countries like the SEEDS, but maybe for other countries as well.

I think that this will be one of the critical roles regional level, ensuring this capacity as a region to respond to all of those questions that you have, like the pooled procurement. Thank you very much.

CHAIR: I shall give the floor to India to ask a question. –

INDIA: Thank you, Chair, for giving me the floor. My question relates to the ongoing restructuring or restructuring process that you’re talking about in terms of global health architecture. The question is that the global health landscape now increasingly includes Gavi, the Global Fund, CEPI, and Pandemic Fund, the World Bank, and large philanthropies. Countries often carry the cost of that fragmentation. Do you see WHO as leading that reform, coordinating it, or being reshaped by it?

What would be a more coherent system look like by the end of your term? And what would WHO itself have to give up? Thank you.

DR MARÍA NEIRA: Thank you very much. And this is really a very important question. Two streams. In five years from now, yes, I would like to see this sovereign need in place, this national capacity, one plan, one delivery, one donor reporting, and all of these align. Thanks, among others, to the support of WHO to create that.

The other stream will be here where we have part of this global health architecture. I will invite you to endorse those recommendations that will come from the different exercises that we are doing at the moment to define a global health architecture. Most of those recommendations will talk as well about WHO taking the central role on these ecosystems of health-related agencies. So WHO will have a mandate on that, recognizing the comparative advantage of all. But I understand as well that one of the strong recommendations is about discipline and coherence by donors, by partners.

We need to really, if we are serious about this global health architecture, and I think we need to very much, we need to ensure discipline as donors, our Member States as well, discipline as international organizations, of course, on making sure that the coherence of the messages we give in one of those institutions is coherent and in consensus with other positions in other organizations. If we create that alignment on a strategic way, again, I think this could facilitate very much the life of the countries, reduce duplications, reduce the reporting, better use of the resources, and what is more important, impact on the health of the people at the end of the exercise. So I really hope that those recommendations can be endorsed in May. And if I am the Director-General of WHO, definitely the priority will be to go ahead with those recommendations as soon as possible. Thank you.

CHAIR: The time allotted for the questions and answers is now exhausted and so is the total time allotted for the interview. Encouraged by all the beautiful language, I would like to wish Dr Neira in my language also. Thank you, Dr Neira, for being with us today. I would ask the Secretary to accompany you out of the room. So this concludes this morning’s session.

We can suspend the meeting and reconvene at 14 hours. Thank you. There’s no translation for my language. I’m afraid not. Vielen Dank.

Afternoon session

CHAIR: Good afternoon. The meeting is called to order. Before proceeding with the next interview, may I please verify that all delegations have received the envelope with the token for the afternoon session.

SECRETARY: No one is putting their hands up, so we assume they have.

CHAIR: So since no one is putting their hands up, we assume everyone has received. This time, be a short, I’ll pick up with my left hand. And we are aware, Derek and me, we are aware. Some countries have been here for the last two days and have never got opportunity to ask and hope and I’m really hoping that they get opportunity to ask. We can now proceed with the interview of Dr Hanan Barkley.

I shall ask the Secretary to bring the candidate into the room. Dr Hanan Barkley: Good afternoon, Dr Hanan Barkley. Welcome to the First Candidates Forum for the election of Director-General. I wish to thank you for coming to this interview today. I understand that the Secretary has already informed you of the way we shall proceed this afternoon, and I propose that we start immediately with your oral presentation.

You have now the floor. The 10-minute period will begin simultaneously with the activation of the lighting system.

Interview of Dr Hanan Balkhy

DR HANAN BALKHY: Good afternoon, Your Excellencies, dear colleagues. It gives me great pleasure to be here with you today to present to you my vision as the I am the Director-General of the World Health Organization, a WHO the world can count on, built on trust, driven by impact, and measured by value. I am your hybrid candidate. I worked along the WHO as a professional, seeking its guidance, leading a collaborating center for 10 years, working as a public health leader at national, regional and global level. I moved to headquarters in Geneva where I established the Division of Antimicrobial Resistance, I worked with UN agencies to ensure global governance, and I mobilized funding to implement national action plans in the Member States along with the regional offices and country offices.

I currently serve as the Regional Director for the Eastern Mediterranean region, where I oversee the health delivery of WHO services of 22 Member States, one of the most difficult regions with large conflicts, countries under sanctions and extensive impact of climate. So you know my track record, it is elaborated in my platform that you have in front of you, And you know that I get things done. I provided in my platform some examples of my leadership. At national level, when I was in the front of managing and working on the MERS-Corona outbreak, not only did I do it as a professional infection control and infectious disease person, but I made sure that I prioritized community engagement in the response and worked to destigmatize the disease. As a regional director, I worked on establishing the financing coalition and leading the global work that we have done in WHO where it was launched from Riyadh, Saudi Arabia, where the coalition included Islamic financing towards global health in cooperation with the Islamic Center for Development of Trade.

I have been able to work with the Member States in my region to mobilize 153 million U.S. Dollars for eight of the Member States from the pandemic fund. We were able to also mobilize 1.6 billion dollars in voluntary contributions between 24 and 25. Ninety percent of that funding is with the countries. Many other examples exist, including the vaccination of over 600,000 children on three cycles in Gaza in the middle of a conflict during very short humanitarian breaks.

But that is not just my track record. I had the honor to be with you at the sides and the margins of six regional committees and in your capitals, and I thank you for the warm welcome that you have given me and guided me where I listened to your admiration of the World Health Organization and your candid in actually being your candid discussion with me on what is working well and what needs improvement. I listened and I absorbed all of your comments. Those discussions have actually helped me develop and finalize my platform. So what exactly did I hear?

I heard from the countries that you want a WHO that you can trust and use its guidance. You want a WHO that actually can be reached with its expertise when and where you want it. You want a WHO that you can articulate its value to your leadership and your people. Collectively, the SDGs vocalized very clearly: they want a WHO, you want a WHO that can lead on global health security, and you want a WHO that can be very verbal and vocal about equity, and you want a WHO that can work with partners and Member States to reach the 2030 SDG goals and beyond. That information has helped me establish my platform, a WHO the world can count on, built on trust, driven by impact, and measured by value.

Trust and impact and value, the three priorities, is the organization that I want to lead with. The nine commitments is the focus on where I’m going to put the efforts in leading the organization. And the six tests of delivery is where you’re going to assess my capacity to lead the organization along with the whole leadership of this organization. The WHO that you are looking forward to is built on trust. So I commit to you today in this presentation that I will strengthen WHO’s focus and accountability.

And I commit that I will deliver science that countries can trust and use, and I commit that I will align WHO and partners and financing for the betterment of serving our Member States. For a WHO that’s driven by impact, I commit to build resilient health care systems, and I commit to detect early, respond fast, and share fairly. And I commit to you that we will leave countries stronger and systems stronger after disasters. For an organization that is measured by value, I commit to strengthen integrated primary healthcare and work with the Member States to protect people from financial hardship. And I commit that I will use the data, use our capacity and my engagement and the engagement of the organization with every single country to make sure that we do not leave anyone behind.

That is my commitment to you. With that, I offer you, Your Excellencies, six tests of delivery. The organization and the WHO measures and produces results. What I’m offering you is to assess how well I’m using those results to improve and to deliver on my commitments. So the six commitments or the six tests of delivery are on clear commitments and accountability, on current usable guidelines, on proven preparedness, on emergency lessons acted on, and on WHO’s contribution visibility and making sure that financial hardship is mitigated.

In my platform you can see the horizon where in the first 100 days, every year after that and the end of the term, I will convene with you and with our governing bodies on how well are we doing and I will make sure that there is a commitment to specific groups of countries that have vocalized that they want their voices heard, that we make sure that there is the platform for them to be heard and to voice their concerns where things are moving well and where things are stalling. And together we will find some of those solutions and respond to them. Your Excellencies, I am ready to lead. As your Director-General, I shall listen widely. I will work with you to explain the difficult choices.

And together we will decide clearly and act firmly when performance falls short. So I ask that I be judged by delivery. Thank you very much, Your Excellencies.

CHAIR: Thank you. Thank you. We will now continue with the questions and answers. I shall now invite Member States and Associate Members wishing to ask the candidates a question to place their grey token in the receptacle corresponding to their region. May I please ask the Secretary to collect the tokens and to display the relevant token on screen.

I shall now pull one token from each of the receptacles following the order of regions previously determined, starting therefore from the African region. Once six tokens, one per region have been pulled out, I will invite the corresponding Member States or associate members to ask questions.

SECRETARY: Thank you. Sudan. Bahamas. Norway. Norway.

India.

CHAIR: Is it in order?

SECRETARY: Yes, sir.

CHAIR: The six members that will be given the floor to ask questions in the seventh and last round are: Ethiopia, Sudan, Bahamas, Norway, Australia and India. I shall now give the floor to Ethiopia to ask a question. The 50-minute period will begin simultaneously with the activation of the lighting system.

ETHIOPIA: All right. Thank you very much, Chair, and thank you so much, Dr Balkhy, for the presentation I’m here. So WHO has made an important progress when it comes to strengthening global health emergency and preparedness and response as well. And if elected Director-General, how would you ensure that? If elected Director-General, how would you ensure that these efforts translate into lasting national capacities, particularly in countries facing workforce and financing constraints while maintaining effective international search support when national capacities are exceeded in strengthening the global health emergency and preparedness and response, I mean?

DR HANAN BALKHY: Thank you. Thank you very much. This question goes to the core of what I’ve been dealing with in the Eastern Mediterranean region. When you look at emergencies and the capacity to deliver, that has to happen before the emergency takes place. What I have led in the Eastern Mediterranean region is to work through our country offices and through the experts that we have at all three levels to ensure that each of those countries has the capacity to develop sustainability in areas where there is no conflict.

The reality on the ground that each of the countries has, that has conflict or has an outbreak, they have other areas within that same country where sustainable work can be developed. And we are doing that actively now in the eastern Mediterranean region. So that’s one part. The second part, in mobilizing, you asked about specifically financing. I have focused on a regional financing health subcommittee that is working there, and that could actually be extrapolated to all different regions.

The essence of it is how do you look into the priorities of the countries and assessing their evaluations of their preparedness and their readiness to respond in an emergency and understand where are the gaps that exist. Once that is identified by the country, we work with them hand in hand to identify sources of funding and financing. One of them after the COVID pandemic was the pandemic fund and you saw that we spoke about, I spoke about eight Member States and there are other regions that have done that as well. Number two that I’ve done on financing is we now need to move into innovative financing, faith-based financing which we’re doing to bring better collaborations on the ground from the diaspora, from the wealthy individuals using those resources to fund priorities. The third and last thing that I will talk about at this point is in the emergency responses, the first responders, and you talked about the health workforce, the first responders are the most critical ones.

They are the ones who are actually going to have the heavy lift and mitigate the emergency if it’s an outbreak at an early stage. We’re working with Member States to make sure that they have those ready first responders. Number two on the capacity at the country level to make sure that we support the Member States in building their own production capacity. And that might come in another question I hope that I can elaborate on. But that is crucial for the independence of the Member States and focusing on the gaps of the health workforce, the EMT specifically.

There’s the G-Hack, there’s many initiatives around the world that are working on that. I will make sure to prioritize it and incentivize inter-regional collaboration and also with the academic centers to make sure that that capacity is groomed and continues to grow.

CHAIR: I shall now give the floor to Sudan to ask a question.

SUDAN: Thank you Mr Chair. Thank you Dr Hanan for this insightful presentation. Despite progress in global health, significant gaps remain in meeting women’s health needs, particularly in low-resource and conflict-affected settings. If elected Director-General, which areas would you prioritize and what concrete actions would you take to address these gaps and improve health outcomes for women in these settings?

DR HANAN BALKHY: This is a critical question. As a mother, as a female, as someone who’s leading a very difficult region, I totally hear you on this question. The situation in Sudan is extremely tough. I’ve visited it four times already, and we’re working very closely with our country office to ensure that the response to the atrocities that are happening on the ground, including gender-based violence, are addressed and highlighted. I deal with that and I take it with utmost seriousness and priority.

The way that I find is the best way to sustain. So these atrocities need to be addressed as they take place, but the preparation and the preparedness of the different Member States is very important. So the best way that I go back, and maybe you’ve been there when I visited Sudan a few times, My question to the Member States and the Ministers, how can we make you need us less? So that means that I’m really focused on development, including in countries that need humanitarian response. So on the women’s issue, it is very important that we establish critical, accessible, affordable primary health care, and make sure that the health workforce is trained and capable of early detection and support of women issues.

We need to make sure that they have the capacity for safe delivery, that they have the capacity for immunization of children and of women. We’ve seen now measles in pregnant women, which is coming back. That’s not a good sign at all. So there are several areas that goes back to the grassroots of solving the problems, which has been my laser focus as a regional director. How are we going to, and with Sudan specifically, we have worked with them on identifying how are they going to bring their manufacturing capacity back.

The manufacturing capacity becomes very important because that’s where the essential medicines to serve the women and the children and everyone. But the priority for women is very high in my agenda. I will make sure that the guidance, the guidelines, the norms and standards, and the golden standard treatment that every woman needs will be also available to the women of Sudan and any other country under conflict. Thank you.

CHAIR: I shall now give the floor to Bahamas to ask a question.

BAHAMAS: Thank you, Chair. WHO has consistently highlighted the importance of regional production and diversified supply chains, yet many small island developing states remain almost entirely dependent on imports for essential medicines and health products. If elected, what specific commitment or initiative would you champion to help SIDS develop local and regional manufacturing capacities for medicines and vaccines and other critical health systems?

DR HANAN BALKHY: Thank you very much. Local production is part of my flagship as the regional director for Eastern Mediterranean region. Again, I took that initiative and I launched it as soon as I became regional director because it is what the Member States wanted. During my tour and discussions with over 100 Member States, I heard the same thing. During my discussions with the Smile Development Island states, I heard the same thing.

I will take that priority to a global level. And there are several areas under that. Number one, we will work with the small islands and with countries that have deficiency in oversight and national regulatory authority, and whether they can use their own and build that capacity, which we can help in doing that. It is part of our mandate, and it’s one of our core functions that we do. Or if there are certain reliance mechanisms that can take place.

Number two, I will prioritize working with the different regions to make sure that we can enhance the pooled procurement processes. For the countries to have access to medications, the producers need to have confirmed and dependable requests. The market shaping becomes very important. So we can bring countries together on their needs to ensure that the pooled procurement goes across regions and that can be supported. The other thing is the pooled procurement, which is very important.

And there are ways that we are actually working with the Member States within the Eastern Mediterranean and also working with the Afro region to ensure that. That is something that I will take to heart as the next Director-General. I will ensure that the regulatory authority and the oversight is something that is built together. I will be working with the Member States to be at the table to make sure that the production capacity is complementary and that we make sure that the essentials are on the list of the manufacturing and the producers, because it’s very important. Other than that, I think I would also like to make sure that the small islands, and this is a commitment that I will make to them, that they will have a voice to speak on a regular basis.

You’ve heard about my horizon of the six tests of delivery. There will be a special platform to discuss the issues of the small development islands on the progress, on the current framework that we have, and also on advancing it, revising it, and making sure that it delivers what it needs to for those Member States. Thank you.

CHAIR: I shall now give the floor to Norway to ask a question.

NORWAY: Thank you, Chair. We need to reform WHO due to financial restrictions and to secure the top priorities. Based on your experience as an ADG and regional director, what do you see as the most important internal reforms WHO should undertake during the next years and how would you begin implementing them in your first years in office? Thank you.

DR HANAN BALKHY: Thank you very much. The reform needs to start immediately and I think there’s already good practices that are being institutionalized, whether because it was an internal desire to do so by the current leadership, which I’m also part of the global policy group, led by the Director-General and with the six other regional directors. So, but if you’re asking me what I would prioritize, there is a desperate need to institutionalize performance in the organization and efficiencies. So those are the two areas where I would start focusing on. As the regional director, I already lobbied quite hard with all of my colleague regional directors and the Director-General.

We started the WR which is the head of country offices succession plan. I’ve established in my own region the WR boot camp and for me that is extremely crucial because the actual delivery is at the country level. So one of my first priorities is how are we going to strengthen the capacity at country level? How are we going to ensure that the heads of the offices and the technical expertise are available at the country office and that we have clear mechanisms for them to extrapolate the expertise from any part of the house so that the Member States get the best out of WHO. On efficiencies, already when I became a regional director, I froze all recruitments until I looked at the overlaps in the programs, and that usually comes with the issue of our earmarked funding and we tried to work with the donors and in fact we decreased overlap and duplicity by one of the great examples is merging the EPI program with the polio program because it was dispersed among three different units.

We merged them together and we created clear pathways of communication between the different units so that there’s more efficiency and stronger collaboration and better delivery to the country offices. So in summary, I will institutionalize managerial areas that improve performance of our staff and improve the access of the countries to our expertise and I will make sure that we decrease duplication and increase efficiency at country level which will have a ripple effect throughout the organization.

CHAIR: I shall now give the floor to Australia to ask a question.

AUSTRALIA: Thank you Dr Balkhy. WHO must serve countries with very different social, political and cultural positions while maintaining universal evidence-based standards. How would you safeguard WHO’s normative work including on sexual and reproductive health and rights in this context? Thank you.

DR HANAN BALKHY: The WHO, first of all, as a scientist and as a physician, health has no, there’s no fogginess in what we need to do for health. Everybody needs to be able to access health care, regardless of, we have to be agnostic to their shape, their color, their religion, their background. Every individual who needs health should be able to access timely, effective and safe health care. That’s number one. On the guidelines, WHO, in producing its norm and standards, it produces it based on science.

As the next Director-General, regardless of which topic, which group we’re talking about, there will always be clear, fair, transparent development of guidelines that the Member States will eventually adopt based on their national policies. So that process should be safeguarded and I commit to you that I will continue to think that way, behave that way and lead the organization with that principle.

CHAIR: I shall now give the floor to India to answer a question.

INDIA: Thank you, Chair. Thank you, Dr Hanan, for your presentation. WHO is being asked to be a standard setter, a technical partner, an emergency responder and a convener of multiple issues, all while absorbing its steepest budget and staff cuts. In years, if you had to define WHO’s course identity for the next decade, what would it be and which functions would you deliberately leave to other institutions? Thank you.

DR HANAN BALKHY: Thank you very much. The prioritization of the work of the WHO is very important to be bottom up. So in developing our GPW-14 and in developing the next GPW-15, we go through a very extensive exercise from the countries all the way up to HQ. In doing so, with the current budget situation, we will continue to prioritize what the Member States actually need when it comes to the technical support. And that is specifically on norms and standards guidelines, on technical guidance on implementation, and our operational work in emergencies in countries that have no other resource to support them.

That is how we need to prioritize the work. There’s other work that can be, that already should be done by other organizations and other entities. And there’s even better than that, that certain countries will start graduating the need for the UN system and for the WHO. That is my aspiration. I want to, I shouldn’t say this openly, but I want to drive us out of business, if I could.

The reality is we want the Member States to be as independent as possible from external aid and I will do everything I can to make that happen and I will oppose to any entity or any group of work within the WHO that continues to make us, the Member States, dependent on us. So the work that we do, the support that we provide, and that is in my impact pillar, it is to leave systems stronger, not to keep the Member States dependent on what we do. So going back to the prioritization, there are areas of work that we have identified that are already duplicate, and by stopping that, we actually save funding for the things that are really needed. The other area is that I stopped as soon as I became regional director were a significant number of workshops that really had no major impact on the ground that were planned, I think 60 of them throughout the biennium. I cancelled all of them.

And unless the Member State requires a specific technical support, then the workshops are not just automatically thrown into the laps of the countries. We make sure that this communication is done based on the needs of the Member States. Thank you.

CHAIR: The first six questions and questions are read out and answers given. The lighting system tracking the 50 minute period will now be supposed. I shall now ask the Secretary to merge the contents of the six receptacles into one and will continue with the selection of Member States or associate members until the time available is exhausted. Each time a question is posed and an answer is provided, the lighting system will be activated to track the one-minute period for the equation and the three-minute period for the response actively. I shall now give the floor to Republic of Korea to ask a question.

REPUBLIC OF KOREA: Thank you Chair. Republic of Korea would like to ask about the composition of WHO’s senior leadership team. If elected, how do you balance technical expertise and management competence with equitable geographical representation when making senior appointments? What transparent selection and accountability arrangements would you establish? And how would you ensure that appointed senior leaders and independently elected regional directors work together effectively across headquarters, regional and country levels?

DR HANAN BALKHY: Thank you very much. I think it’s time for the organization to start having clear and transparent post descriptions. So when we talk about the composition of the leadership underneath the Director-General, the decision on having different leadership titles such as the deputy Director-General, the assistant Director-General, the executive director for emergencies program, There needs to be clarity on the post descriptions and there needs to be a fair and transparent selection process that I will apply to make sure that the leadership is selected and not appointed based on specific criteria and an interview process to ensure that the person that is going to lead on that specific area has the right qualification and is capable of moving that agenda forward. The second thing that is important that there needs to be at any level of leadership, I have put forward six tests of delivery. So I expect that also for the leaders to also have an assessment process and a compact.

As an ADG, I did have a compact and I did sit with my supervisor at the time, which was the deputy Director-General. That process needs to continue to understand what is going well and what needs to be fixed and where are the challenges taking place. On how I will lead with the elected regional directors, I think I will be one of the most compassionate director generals because I was an ADG and I know what it felt like. And now I am a regional director and I know what it feels like. So there are a lot of good things that are happening in the relationship between the leadership.

I can tell you as of now, the GPG meets almost weekly. And there’s a lot of communication, a lot of collaboration, I will strengthen that. I will make sure that the leadership has very open and consistent and structured communication style and that we bring to each other the problems that we’re facing and the solutions that can happen and the learning process from the different regions and the different offices to each other and that all of us support the work and the function that the country offices are actually doing on a daily basis. So that’s a great question and a very important one. Thank you.

CHAIR: I shall now give the floor to Egypt to ask a question.

EGYPT: Yes. Dr Balkhy, in view of your leadership of the Regional Office for Eastern Mediterranean, which combines acute emergencies with long-term programs such as polio eradication and multi-disease elimination strategies that you innovated in this region, and in view of many flagship initiatives that you have led, looking back on your tenure what is the single most important lesson from leading a region in crisis that you would apply to the organization as a whole and what is the one thing the one thing that didn’t work as intended that you would do differently as Director-General? Thank you.

DR HANAN BALKHY: Thank you for that question. The one thing that worked well and I think I would love to see further fruits to gain is listening. Listening to the Member States and not judging them. That’s extremely important. You mentioned polio.

I’ve been to Afghanistan four times and I’ve been to Kandahar, Mazar-I-Sharif and Kabul. So I’ve toured that country a little but I’ve been to every single Member State except for one so far in my region. And the most critical part that they appreciate is listening to what their needs are and to be agile in responding to and finding solutions for their problems. So as a health organization, it’s not just about norms and standards, and this is something that I’ll take the opportunity to elaborate on. The WHO in the work that we do and in the educational experience that I’ve had leading the region, it is not just about setting norms and standards.

It is about how are they going to be applied in Member States, specifically difficult Member States like the ones that we have across the world and we have also in the eastern Mediterranean region. So listening is extremely important. The one thing that did not work well, there’s a lot, but… The thing is that I’m not a giver-upper, so if something has not worked well, it doesn’t mean that I’ve dropped it. I’m probably working on it in another context or with a different mindset.

So for me, when something is not working, I’m always consulting with my leadership. I’m consulting with our colleagues in HQ, with the Director-General himself. I consult with the Member States again and again. We will always find a solution. But I can’t think of something that I gave up on or is just not working.

I will come back to you on that if I do think of something. Thank you.

CHAIR: I shall give the floor to Brazil to ask a question.

BRAZIL: Thank you Mr Chair. Hi Dr Balkhy. Which initiatives do you consider a priority for reducing inequalities in access to vaccines, medicines, diagnostics and other health technologies? I thank you.

DR HANAN BALKHY: Dr We go back to the issue of equity which is very important and something that As WHO, we believe, I believe that everybody should have access. So it depends on the context. If we’re talking about a country where there are inequalities because of lack of paying attention to it as an issue, then that will be shown in us working on data. And it’s important that we work with our Member States and their public health authorities on establishing data to understand where is access deficient and what can be done to improve on it. The other issue with inequity could be from one country to another.

And we’ve heard the example of the Small Island Developing States. And I gave a lengthy response on that. We need to understand how can we better improve countries on their independence, on securing their essential medicines list, their essential and primary immunizations. So I will work with the Member States. So on the solutions, I will work with the Member States, as I said, to bring the access initiative in a more robust and more comprehensive and more inclusive of the different regions to work together on how do we secure vaccines, diagnostics, and therapeutics.

In the context of emergencies, which is, again, so there’s different scenarios that can take place. In the context of emergencies, I’m very hopeful. I’m impressed nobody asked me about PABS yet, which is good. The pandemic treaty has been approved. We’re waiting for the PABS to be approved.

And I think the equity there between the Member States in accessing emerging and new products for emerging pathogens is going to be something as the next Director-General I will and will be focusing on. So we’ll see how far this goes before the next Director-General takes office. I will work with the Member States so that we do not repeat the vaccine diagnostic therapeutic nationalism that we saw during the COVID pandemic and to work on better solidarity processes together. And again, I think you can see what’s happening in Africa leading a South-South collaboration with the Accra Reset. I will fully support that.

That will also assist in bringing better equity. Thank you.

CHAIR: I shall now give the floor to Sri Lanka to ask a question.

SRI LANKA: Thank you, Chair. Thank you, Dr Balkhy, for the presentation. In your presentation, you have stated that you are committed to strengthening integrated primary care. If elected, would you support countries, especially the developing countries, in implementing their national priorities in strengthening the primary health care and in achieving universal health coverage? Please, thank you.

DR HANAN BALKHY: Yes, this will definitely be a priority because if we’re talking again about equity, the WHO through again its regional offices and country offices, we will work together on better establishing mechanisms to support the building blocks of primary health care. But it’s not about buildings that have physicians only. It’s an integrated system that has an escalation from primary to secondary and tertiary health care. It needs to be linked to surveillance. It needs to be linked to warehouses and access to medications.

So what we will need to do with specific Member States is to identify where are there gaps, and again, going back to financing national agendas to make this a reality and to make it happen, I will work with the Member States on establishing innovative mechanisms to fund and finance those programs. And I’ve already been doing that, as I said, in the eastern Mediterranean region. Where one of our Member States, we developed together a WHO private public council to support the national public health priorities in that country, and primary health care and access to medicine was one of them. We need to start thinking about how are we going to ensure, if we’re not able to increase the fiscal space for health in that country, how can we bring further funding into the country through innovative methodology. And there’s a plethora of funding out there.

The question is, how do we make it appeasing or attractive to the funders and the donors, also working through the development banks as well to support. Then, at the country level, the other part that is extremely important in the primary healthcare, how are we going to support the warehouses where the medications are stored? How are we going to be innovative in countries that are dispersed among different islands, or they have a country with very high mountains and very low valleys. So innovation, AI, digital and telemedicine, virtual hospitals, there’s a lot of areas that we can start working with, and there are a lot of countries around the world that are willing to help and partner with developing countries to make this happen. So we’re entering a new era of innovation and AI, and I think that primary healthcare will have a very different face in the next few years.

And WHO will be standing there. Hopefully, we will be ahead of the curve in being able to support developing countries on their primary healthcare agenda.

CHAIR: I shall now give the floor to Spain to ask a question.

SPAIN: Gracias. Thank you. The World Health Organization is an organization that is global, a global organization, which means that all Member States should, of course, belong to the World Health Organization. But what sort of reforms do you foresee to come back to this global nature of the World Health Organization? Could you tell us a little bit more about this?

Thank you.

DR HANAN BALKHY: If I understood the question, your question is how do we keep WHO global, correct? Yes. The Member States of the WHO are 194 countries. We will continue to work with all of the Member States. The door is always open for all Member States to be part of the WHO.

I will work as the Director-General to ensure, again, the trust is extremely important. So in creating that inclusivity of the WHO and its global mandate, we will continue to build the trust that we serve all Member States, that we are the UN science-based organization on health. We will improve and continue to provide the necessary guidance, norms and standards that the Member States will benefit from. By doing that, I feel that the global entity or the global nature of the WHO will be sustained as long as we’re capable of working with everyone and we’re capable of producing the guidelines that can be translated into usable guidance to all of the Member States. I hope if I did not answer the question, please, you can repeat it if it was not clear.

CHAIR: I shall now give the floor to Chad to ask a question.

CHAD: Merci. Thank you very much, Mr Chair. Good afternoon, Dr Hanan. If there’s a figure that should question the pertinence of our organization, it would be mortality of women linked to pregnancy and childbirth. Two women every two minutes these are w w ho figures what can be envisaged to improve this poor performance that is no not a compliment for anyone in this room.

Thank you. Thank you.

DR HANAN BALKHY: You’re speaking, Your Excellency, thank you for that, on the maternal mortality rate, which the WHO and SDGs have shown a target of less than 70 deaths per 100,000 live births. In my own region, I have countries with a single digit of their maternal mortality rate and countries with three digits. So indeed, this is something that is of great concern. And our colleague from Sudan probably also asked a question in the similar fashion. The maternal mortality rate, there are great examples, and especially from the African continent, on leadership at the highest level of government in supporting innovative ways to improve women’s access to care during their pregnancy and intrapartum.

I will work to make sure, and I think that this is something that I hope to create a champion group of heads of states leaders to lead and to champion the initiative on mitigating maternal mortality rate. It is extremely critical that we utilize the resources that we have to create stronger advocacy on making sure that women can reach care so that they do not have this significantly unfortunate outcome. I think that in doing that we go back to the basics of each country, understanding where are the toughest areas that this has not been solved yet, what are their specific challenges and how can we start solving them. I will be working with the regional offices and with the country offices of countries that have the highest mortality rates and understand how to better improve on that. In one of my own countries, in the eastern Mediterranean region, there has been a clear focus again on primary health care in some of the provinces of one of the Member States.

In that Member State, there’s not one single obstetrician in several of its provinces. So one of the very first solutions for that, and the government is working with us on how to start training midwifery and how to be able to create innovative ways. It’s a bit of a mountainous country, but again, the solutions come from the country. The WHO supports, monitors with them, and assists in creating the solutions for that specific health topic. It will be a priority for me as the next Director-General.

No question.

CHAIR: I shall now give the floor to Iceland to ask a question.

ICELAND: Thank you and good afternoon. The global health landscape has become increasingly fragmented with many actors overlapping mandates and competing funding streams. Member States have started a joint process to reform the global health architecture and WHO’s role in it will be central to that project. If elected, what is your vision for the future global health architecture and how will you ensure continued political commitment, coordination and momentum to carry forward the joint process to support reforms? Thanks.

DR HANAN BALKHY: Thank you. Again, I’ll go back to what I’m leading now and what my vision is as Director-General. Right now, as the Eastern Mediterranean Regional Director, I lead an entity called the Regional Health Alliance with 18 UN agencies, where we sit together, we decide on the work that we do, we understand each other’s functions that are currently taking place, and not just the mandates, but what is actually taking place. The Regional Health Alliance mirrors what exists at country level, which is the UN country teams. Some of the Member States have over 18, 19 UN agencies and others functioning at country level.

As you said, I’m just reiterating and explicitly saying the level of overlap and the level of competition or crowdedness at the country level. The next Director-General is going to have to act based on what he or she inherits in the global health architecture. Where have the discussions that are taking place currently and what is going to come out of the UNAT? So it’s not the pure decision of the Director-General nor in his or her own capacity. But what I will do very concretely is I will first of all make sure that we as WHO at all our three levels understand exactly our mandate and our roles and responsibility.

I will empower and work with the regional directors and the country offices to make sure that that is also translated at regional and country level. I will make sure that we work with our partner and our colleagues in the other UN agencies to explicitly discuss that. And I have done that. This is not going to be new for me, nor is it going to be, you know, a new idea. When we had in one of our Member States an issue with drug addiction and drug trafficking, The WHO already had an MOU between the UN Office of Drugs and Crime and the WHO, which I fully activated, where we worked side by side.

The WHO did not encroach on the UNODC mandate, and neither did the UNODC encroach on the WHO mandate. This is going to be a very important process and a very important responsibility of the next Director-General to make those tough, consistent, clear discussions with the regional directors and the country offices and with the UN agencies to respect and understand each mandate and to move forward. I’ll stop here in case there’s any extra information that is needed on this.

CHAIR: I shall now give the floor to Belgium to ask a question.

BELGIUM: Thank you, Chair, and thank you, Dr Balkhy, for your presentation. You have put trust, impact, and value at the center of your vision. How would you translate these principles into the organization’s day-to-day work at country level with measurable and sustainable impact, particularly in areas where results are difficult to measure in the short term? Thank you.

DR HANAN BALKHY: Thank you. Thank you very much. So if you look at the details of my platform, there will be more details, but I’ll give you some examples of how this can potentially and hopefully work. On the trust part for science, if we take that for example, what worries me is that today there are a large number of new products for certain diseases, such as tuberculosis, for example, that are coming through the pipeline. The WHO needs to be ready to make sure that they can have the appropriate information to incorporate these new products into the current guidelines so that the guidelines can be living documents and relevant to the diseases that it needs to treat.

So I will work to enhance the machinery of improving the science development, from science development, sorry, to guideline development, to the essentials medicines list, to the implementation process through the regional office and country offices when it comes to the at the country level. In the trust part at country level, what the countries have mentioned to me on trust for example, is that they do not see in some of our guidelines the science that is used that represents their communities. Some of them are native communities to some of these countries. So as WHO we have a heavy lift to work with the Member States and with the science entities and with the academia to make sure that they include communities that are not represented in the science because the guidelines are dependent on the science and the policy is dependent on the guidelines. Again, it’s an area of work that I’ve dealt with a lot as a scientist myself and also leading the Medicines and Health Products Division in Geneva for some time as an interim ADG and also as part of my flagship on access, which includes this area.

On the impact, I’ll give you another example. I have another 58 seconds. On how am I going to do that on impact? The trust of the countries for the WHO on the impact is how are we going to use our intraoperative or intraoperational response to any disasters to better improve the response of the country. The COVID pandemic taught us a lot, and we understood from the JEEs and the SPARS and the preparedness assessments that many countries felt confident that they’re capable of responding.

What we need to do more now after the COVID pandemic is to work with the Member States to make sure that they are truly ready, to make sure that we can work with their entities for them to go over further drills and experimentations on are they truly ready to respond or not. The WHO can help in that capacity, and then we can work with them together to ensure that they resurrect and they improve on what needs to be improved. Thank you.

CHAIR: I shall now give the floor to Syrian Arab Republic.

SYRIAN ARAB REPUBLIC: Thank you, Mr President. We would like to welcome Dr Balkhy, and we would like to appreciate her excellent career as well as her efforts at the head of EMRO. Dr Balkhy, in light of this light, expensive experience, how do you see the role of WHO in helping countries in conflicts and how they can rebuild their health systems and building their capacities in order to ensure sustainability in accessing healthcare. Thank you very much and good luck.

DR HANAN BALKHY: Thank you very much, Your Excellency, for the question. Syria is one of the countries I visited four times, and it has been a true honor to support such a country in coming out of conflict. The best way, as I have mentioned in my manifesto or my platform, countries in conflict don’t have conflict everywhere in the country. So one of the first things that I will do in working with the Member States is to make sure that we have a clear agenda with them on what are their national priorities and where do they see the most important need. So that when it comes to establishing response.

Now in some of the conflicts that have been quite dramatic, there was total destruction for example of healthcare settings. And in that what we have done in the Eastern Mediterranean region in supporting some of the Member States is how do we help the Member States ensure that the basic needs of the people are actually responded to. In the access initiative again that we can make sure that they have their essential medicines list, that they are capable of producing their own medications that are needed, and if not, that they can join a pulled procurement process and they can join other Member States in ensuring that they do have access. One of the other areas is some of the countries under conflict get funding for certain responses. I’ll give you a clear example.

During COVID, one of the countries in conflict was supported by warehouses for the COVID vaccine. What we did in that specific country, we worked with them to make sure that that establishment continued after COVID to support the primary health care needs of the country. Other examples, again during COVID, where Member States were in desperate need of oxygen, what we did is institutionalizing or making sure that we’re not working only on a humanitarian response that is temporary, but we’re merging the humanitarian response with the development capacity of that certain Member State. And that is not very difficult to do if you are thinking about it. And in our region, that has now become the mindset.

In dealing with countries under humanitarian and conflict that are part of a conflict, we make sure that the humanitarian response, even coming from donors, are directed to produce sustainable capacity for the country after the conflict is over. Thank you.

CHAIR: I wish to thank you, Dr Balkhy, for being with us today. And I would ask the Secretary to accompany you out of the room. Gracias. This concludes this afternoon session and the interviews of the candidates for the Director-General. Excellencies, dear Member States, it has been a privilege to preside over the first candidate forum during the past two days.

I would like to thank every candidate for their presentations that informed the discussion, and I wish each one of you the very best in your candidacy for the pose of Director-General. I thank all the Member States for your active participation for the thoughtful questions you put to the candidates. Your engagement has made this forum a valuable exchange. The web forum will begin next week. I will encourage all Member States and the candidates to be fully engaged in this process where we meet before we meet at the Executive Board 160th session in January, 2027.

I also wish to thank the officers of Executive Board, my colleagues who traveled to support me in presiding over this forum. I thank you for your collaboration meaningful discussion we had at our shared lunch today. I would also like to thank the Secretary for all the preparations and briefings you have provided over the past month. I thank the technical teams, the usurers, the interpreters for their commitment to ensure that this meeting was a success. To those travelling to home, I wish you a safe journey and I look forward to seeing you all at the Executive Board in January 2027.

I now declare the first candidates forum closed. Thank you. Thank you.

Legal disclaimer: unofficial ad hoc transcript

This is an unofficial, ad hoc, clean verbatim transcript of the First Candidates’ Forum for the election of the WHO Director-General, held on 19 November 2026. The Geneva Learning Foundation (TGLF) produced it independently by editing automatic speech-to-text output from the English audio channel of the public webcast. This transcript was not created by the World Health Organization (WHO). WHO is not responsible for its content or accuracy. It is not an official record of WHO, the World Health Assembly or the Executive Board. No WHO official, candidate, Member State or other speaker has reviewed or endorsed it. The English channel includes simultaneous interpretation, which is not an authentic or verbatim record. For statements made in other languages, this transcript records the interpretation, not the original. Non-English passages appear as automatically recognized. English renderings in square brackets are informal TGLF translations, not WHO translations. Editing removed fillers, repetitions and audio artefacts, added punctuation, corrected apparent errors in names and terms, and inferred who was speaking. Because these steps involve judgement, the transcript may contain omissions, misattributions, mistranslations and other errors. Square brackets mark insertions, gaps, inferred speakers and uncertain readings. Only the statements as delivered are authentic, as preserved in the official WHO webcast and any official WHO records, which prevail in case of discrepancy. Do not rely on this transcript as an authoritative account, or quote it as a statement of any person, Member State or WHO, without checking the webcast. Naming a person, Member State, organization or position implies no endorsement of any candidate by WHO or TGLF. WHO does not endorse TGLF or this document. The WHO name and emblem may not be used in connection with it. TGLF provides this document “as is”, without warranty of any kind, express or implied. Readers are responsible for how they interpret and use it. To the extent permitted by applicable law, TGLF accepts no liability for damages arising from its use. Errors in this transcript are the responsibility of TGLF alone, not of WHO or of the speakers.

Get access to the latest opportunities

Subscribe now to receive the latest opportunities from The Geneva Learning Foundation (TGLF).

We first request your permission to send you email. Please look for this secure e-mail in your inbox and click on the safe link it contains.